Combination treatment alteration methods and systems

ABSTRACT

Methods, computer program products, and systems are described that include detecting at least one indication of bioactive agent use by an individual and/or altering an artificial sensory experience to modify at least one effect of the bioactive agent.

CROSS-REFERENCE TO RELATED APPLICATIONS

The present application is related to and claims the benefit of theearliest available effective filing date(s) from the following listedapplication(s) (the “Related Applications”) (e.g., claims earliestavailable priority dates for other than provisional patent applicationsor claims benefits under 35 USC §119(e) for provisional patentapplications, for any and all parent, grandparent, great-grandparent,etc. applications of the Related Application(s)).

RELATED APPLICATIONS

-   -   For purposes of the USPTO extra-statutory requirements, the        present application constitutes a continuation-in-part of U.S.        patent application Ser. No. 12/150,122, entitled COMBINATION        TREATMENT SELECTION METHODS AND SYSTEMS, naming RODERICK A.        HYDE; MURIEL Y. ISHIKAWA; ERIC C. LEUTHARDT; ROYCE A. LEVIEN;        ROBERT W. LORD; MARK A. MALAMUD; ELIZABETH A. SWEENEY; LOWELL L.        WOOD, JR.; AND VICTORIA Y. H. WOOD as inventors, filed Apr. 24,        2008 which is currently co-pending, or is an application of        which a currently co-pending application is entitled to the        benefit of the filing date.    -   For purposes of the USPTO extra-statutory requirements, the        present application constitutes a continuation-in-part of U.S.        patent application Ser. No. 12/152,266, entitled COMBINATION        TREATMENT MODIFICATION METHODS AND SYSTEMS, naming RODERICK A.        HYDE; MURIEL Y. ISHIKAWA; ERIC C. LEUTHARDT; ROYCE A. LEVIEN;        ROBERT W. LORD; MARK A. MALAMUD; ELIZABETH A. SWEENEY; LOWELL L.        WOOD, JR.; AND VICTORIA Y. H. WOOD as inventors, filed May 13,        2008, now abandoned, or is an application of which an        application is entitled to the benefit of the filing date.

The United States Patent Office (USPTO) has published a notice to theeffect that the USPTO's computer programs require that patent applicantsreference both a serial number and indicate whether an application is acontinuation or continuation-in-part. Stephen G. Kunin, Benefit ofPrior-Filed Application, USPTO Official Gazette Mar. 18, 2003, availableat http://www.uspto.gov/web/offices/com/sol/og/2003/week11/patbene.htm.The present Applicant Entity (hereinafter “Applicant”) has providedabove a specific reference to the application(s) from which priority isbeing claimed as recited by statute. Applicant understands that thestatute is unambiguous in its specific reference language and does notrequire either a serial number or any characterization, such as“continuation” or “continuation-in-part,” for claiming priority to U.S.patent applications. Notwithstanding the foregoing, Applicantunderstands that the USPTO's computer programs have certain data entryrequirements, and hence Applicant is designating the present applicationas a continuation-in-part of its parent applications as set forth above,but expressly points out that such designations are not to be construedin any way as any type of commentary and/or admission as to whether ornot the present application contains any new matter in addition to thematter of its parent application(s).

All subject matter of the Related Applications and of any and allparent, grandparent, great-grandparent, etc. applications of the RelatedApplications is incorporated herein by reference to the extent suchsubject matter is not inconsistent herewith.

TECHNICAL FIELD

This description relates to methods and systems for combining medicinewith an artificial sensory experience.

SUMMARY

In one aspect, a method includes but is not limited to detecting atleast one indication of bioactive agent use by an individual andaltering an artificial sensory experience to modify at least one effectof the bioactive agent. In addition to the foregoing, other methodaspects are described in the claims, drawings, and text forming a partof the present disclosure.

In one or more various aspects, related systems include but are notlimited to circuitry and/or programming for effecting theherein-referenced method aspects; the circuitry and/or programming canbe virtually any combination of hardware, software, and/or firmwareconfigured to effect the herein-referenced method aspects depending uponthe design choices of the system designer.

In one aspect, a system includes but is not limited to means fordetecting at least one indication of bioactive agent use by anindividual and means for altering an artificial sensory experience tomodify at least one effect of the bioactive agent. In addition to theforegoing, other method aspects are described in the claims, drawings,and text forming a part of the present disclosure.

In one aspect, a system includes but is not limited to circuitry fordetecting at least one indication of bioactive agent use by anindividual and circuitry for altering an artificial sensory experienceto modify at least one effect of the bioactive agent. In addition to theforegoing, other method aspects are described in the claims, drawings,and text forming a part of the present disclosure.

In one aspect, a computer program product includes but is not limited toa signal-bearing medium bearing one or more instructions for detectingat least one indication of bioactive agent use by an individual and oneor more instructions for altering an artificial sensory experience tomodify at least one effect of the bioactive agent. In addition to theforegoing, other method aspects are described in the claims, drawings,and text forming a part of the present disclosure.

In one aspect, a system includes but is not limited to a computingdevice and instructions that when executed on the computing device causethe computing device to detect at least one indication of bioactiveagent use by an individual and alter an artificial sensory experience tomodify at least one effect of the bioactive agent. In addition to theforegoing, other method aspects are described in the claims, drawings,and text forming a part of the present disclosure.

The foregoing is a summary and thus may contain simplifications,generalizations, inclusions, and/or omissions of detail; consequently,those skilled in the art with appreciate that the summary isillustrative only and is NOT intended to be in any way limiting. Otheraspects, features, and advantages of the devices and/or processes and/orother subject matter described herein will become apparent in theteachings set forth herein.

BRIEF DESCRIPTION OF THE FIGURES

FIG. 1 illustrates an exemplary environment in which one or moretechnologies may be implemented.

FIG. 2 illustrates an operational flow representing example operationsrelated to selecting a combination of at least one prescriptionmedication and at least one artificial sensory experience.

FIG. 3 illustrates an alternative embodiment of the operational flow ofFIG. 2.

FIG. 4 illustrates an alternative embodiment of the operational flow ofFIG. 2.

FIG. 5 illustrates an alternative embodiment of the operational flow ofFIG. 2.

FIG. 6 illustrates an alternative embodiment of the operational flow ofFIG. 2.

FIG. 7 illustrates an alternative embodiment of the operational flow ofFIG. 2.

FIG. 8 illustrates an alternative embodiment of the operational flow ofFIG. 2.

FIG. 9 illustrates an alternative embodiment of the operational flow ofFIG. 2.

FIG. 10 illustrates an alternative embodiment of the operational flow ofFIG. 2.

FIG. 11 illustrates an alternative embodiment of the operational flow ofFIG. 2.

FIG. 12 illustrates an alternative embodiment of the operational flow ofFIG. 2.

FIG. 13 illustrates an alternative embodiment of the operational flow ofFIG. 2.

FIG. 14 illustrates an alternative embodiment of the operational flow ofFIG. 2.

FIG. 15 illustrates an alternative embodiment of the operational flow ofFIG. 2.

FIG. 16 illustrates an alternative embodiment of the operational flow ofFIG. 2.

FIG. 17 illustrates an alternative embodiment of the operational flow ofFIG. 2.

FIG. 18 illustrates an alternative embodiment of the operational flow ofFIG. 2.

FIG. 19 illustrates an alternative embodiment of the operational flow ofFIG. 2.

FIG. 20 illustrates an alternative embodiment of the operational flow ofFIG. 2.

FIG. 21 illustrates an alternative embodiment of the operational flow ofFIG. 2.

FIG. 22 illustrates an alternative embodiment of the operational flow ofFIG. 2.

FIG. 23 illustrates an alternative embodiment of the operational flow ofFIG. 2.

FIG. 24 illustrates an alternative embodiment of the operational flow ofFIG. 2.

FIG. 25 illustrates an alternative embodiment of the operational flow ofFIG. 2.

FIG. 26 illustrates an alternative embodiment of the operational flow ofFIG. 2.

FIG. 27 illustrates an alternative embodiment of the operational flow ofFIG. 2.

FIG. 28 illustrates an alternative embodiment of the operational flow ofFIG. 2.

FIG. 29 illustrates an operational flow representing example operationsrelated to selecting a combination of at least one prescriptionmedication and at least one artificial sensory experience.

FIG. 30 illustrates a computer program product related to selecting acombination of at least one prescription medication and at least oneartificial sensory experience.

FIG. 31 illustrates a system related to selecting a combination of atleast one prescription medication and at least one artificial sensoryexperience.

FIG. 32 illustrates an exemplary environment in which one or moretechnologies may be implemented.

FIG. 33 illustrates an operational flow representing example operationsrelated to modifying at least one artificial sensory experience.

FIG. 34 illustrates an alternative embodiment of the operational flow ofFIG. 33.

FIG. 35 illustrates an alternative embodiment of the operational flow ofFIG. 33.

FIG. 36 illustrates an alternative embodiment of the operational flow ofFIG. 33.

FIG. 37 illustrates an alternative embodiment of the operational flow ofFIG. 33.

FIG. 38 illustrates an alternative embodiment of the operational flow ofFIG. 33.

FIG. 39 illustrates an alternative embodiment of the operational flow ofFIG. 33.

FIG. 40 illustrates an alternative embodiment of the operational flow ofFIG. 33.

FIG. 41 illustrates an alternative embodiment of the operational flow ofFIG. 33.

FIG. 42 illustrates an alternative embodiment of the operational flow ofFIG. 33.

FIG. 43 illustrates a computer program product related to selecting acombination of at least one prescription medication and at least oneartificial sensory experience.

FIG. 44 illustrates a system related to selecting a combination of atleast one prescription medication and at least one artificial sensoryexperience.

DETAILED DESCRIPTION

In the following detailed description, reference is made to theaccompanying drawings, which form a part hereof. In the drawings,similar symbols typically identify similar components, unless contextdictates otherwise. The illustrative embodiments described in thedetailed description, drawings, and claims are not meant to be limiting.Other embodiments may be utilized, and other changes may be made,without departing from the spirit or scope of the subject matterpresented here.

FIG. 1 illustrates a system 100 for accepting at least one attribute ofat least one individual, querying at least one database at least partlybased on the at least one attribute, selecting from the at least onedatabase at least one prescription medication and at least oneartificial sensory experience to address the at least one attribute ofat least one individual, and presenting an indication of the at leastone prescription medication and the at least one artificial sensoryexperience at least partly based on the selecting from the at least onedatabase at least one prescription medication and at least oneartificial sensory experience to address the at least one attribute ofat least one individual. The system 100 may include acceptor module 102,querier module 104, selector module 106, presenter module 108,implementer module 138, and/or modifier module 140. Acceptor module 102may receive attribute 120 from network storage 110, memory device 112,database entry 114, and/or user interface 116. User interface 116 mayreceive information from user 118. User 118 may include health careprovider 136. Querier module 104 may search database 122. Database 122may include medication database 124 and/or artificial sensory experiencedatabase 126. Presenter module 108 may present to health care provider128, output device 130, and/or individual 134. Output device 130 mayinclude mobile device 132. Modifier module 140 may include restrictormodule 142, granter module 144, alterer module 146, adder module 148,deleter module 150, and/or acceptor module 152. System 100 generallyrepresents instrumentality for accepting at least one attribute of atleast one individual, querying at least one database at least partlybased on the at least one attribute, selecting from the at least onedatabase at least one prescription medication and at least oneartificial sensory experience to address the at least one attribute ofat least one individual, and presenting an indication of the at leastone prescription medication and the at least one artificial sensoryexperience at least partly based on the selecting from the at least onedatabase at least one prescription medication and at least oneartificial sensory experience to address the at least one attribute ofat least one individual. The operations of accepting at least oneattribute of at least one individual, querying at least one database atleast partly based on the at least one attribute, selecting from the atleast one database at least one prescription medication and at least oneartificial sensory experience to address the at least one attribute ofat least one individual, and presenting an indication of the at leastone prescription medication and the at least one artificial sensoryexperience at least partly based on the selecting from the at least onedatabase at least one prescription medication and at least oneartificial sensory experience to address the at least one attribute ofat least one individual may be accomplished electronically, such as witha set of interconnected electrical components, an integrated circuit,and/or a computer processor.

FIG. 2 illustrates an operational flow 200 representing exampleoperations related to accepting at least one attribute of at least oneindividual, querying at least one database at least partly based on theat least one attribute, selecting from the at least one database atleast one prescription medication and at least one artificial sensoryexperience to address the at least one attribute of at least oneindividual, and/or presenting an indication of the at least oneprescription medication and the at least one artificial sensoryexperience at least partly based on the selecting from the at least onedatabase at least one prescription medication and at least oneartificial sensory experience to address the at least one attribute ofat least one individual. In FIG. 2 and in following figures that includevarious examples of operational flows, discussion and explanation may beprovided with respect to the above-described examples of FIG. 1, and/orwith respect to other examples and contexts. However, it should beunderstood that the operational flows may be executed in a number ofother environments and contexts, and/or in modified versions of FIG. 1.Also, although the various operational flows are presented in thesequence(s) illustrated, it should be understood that the variousoperations may be performed in other orders than those which areillustrated, or may be performed concurrently.

After a start operation, the operational flow 200 moves to an operation210. Operation 210 depicts accepting at least one attribute of at leastone individual. For example, as shown in FIG. 1, acceptor module 102 mayaccept at least one attribute of at least one individual. In oneinstance, acceptor module 102 can accept from a user 118 and a userinterface 116 an attribute 120 including an attribute of a personalhealth history associated with an individual named John Smith. In someinstances, acceptor module 102 may include a computer processor.

Then, operation 220 depicts querying at least one database at leastpartly based on the at least one attribute. For example, as shown inFIG. 1, querier module 104 may search at least one database at leastpartly based on the at least one attribute. In one example andcontinuing with the previous example, querier module 104 can search adatabase 122 including a medication database 124 and artificial sensoryexperience database 126 at least partly based on the attribute includingan attribute of a personal health history associated with an individualnamed John Smith. In some instances, querier module 104 may include acomputer processor.

Then, operation 230 depicts selecting from the at least one database atleast one prescription medication and at least one artificial sensoryexperience to address the at least one attribute of at least oneindividual. For example, as shown in FIG. 1, selector module 106 mayselect from the at least one database at least one prescriptionmedication and at least one artificial sensory experience to address theat least one attribute of at least one individual. In one instance andcontinuing with the previous example, selector module 106 can selectfrom a medication database 124 and artificial sensory experiencedatabase 126 a prescription medication and an artificial sensoryexperience for addressing the attribute 120 including an attribute of apersonal health history associated with an individual named John Smith.In some instances, selector module 106 may include a computer processor.

Then, operation 240 depicts presenting an indication of the at least oneprescription medication and the at least one artificial sensoryexperience at least partly based on the selecting from the at least onedatabase at least one prescription medication and at least oneartificial sensory experience to address the at least one attribute ofat least one individual. For example, as shown in FIG. 1, presentermodule 108 may present the at least one prescription medication and theat least one artificial sensory experience at least partly based on thesearching at least one database at least partly based on the at leastone attribute. In one instance and continuing with the previous example,presenter module 108 can present to a medical professional theprescription medication and the artificial sensory experience based onsearching the medication database 124 and artificial sensory experiencedatabase 126 based on the at least one attribute 120 including anattribute of a personal health history associated with an individualnamed John Smith. In some instances, presenter module 108 may include acomputer processor.

FIG. 3 illustrates alternative embodiments of the example operationalflow 200 of FIG. 2. FIG. 3 illustrates example embodiments where theoperation 210 may include at least one additional operation. Additionaloperations may include an operation 302.

Operation 302 illustrates accepting at least one physical enhancementgoal associated with the at least one individual. For example, as shownin FIG. 1, acceptor module 102 may accept from a database entry 114 atleast one physical enhancement goal associated with the at least oneindividual. In one instance and continuing with the above example,acceptor module 102 accepts from memory device 112 at least one physicalenhancement goal associated with an individual named John Smith. Aphysical enhancement goat may include a physical state and/or situationan individual may plan to achieve. Some examples of a physicalenhancement goal may include achieving a certain state of relaxation,reaching a certain body mass, maintaining a specific cholesterol level,achieving an athletic performance goat, and/or lowering a blood pressurelevel. In some instances, acceptor module 102 may include a computerprocessor.

FIG. 4 illustrates alternative embodiments of the example operationalflow 200 of FIG. 2. FIG. 4 illustrates example embodiments where theoperation 210 may include at least one additional operation. Additionaloperations may include an operation 402, an operation 404, and/or anoperation 406.

Operation 402 illustrates accepting at least one physical attributeassociated with the at least one individual. For example, as shown inFIG. 1, acceptor module 102 may accept from network storage 110 at leastone physical attribute associated with the at least one individual. Inone instance, acceptor module 102 can accept a physical attribute 120associated with a group of twenty individuals including an individualweight for each individual. A physical attribute may include anattribute that may be described and/or detected using senses, that hassubstance and/or a material existence, and/or that may be acted upon byphysical force. Some examples of a physical attribute may include abiochemical measurement such as blood sugar level, a smelt, anappearance, a physiological measurement such as blood pressure, and/orskin conductivity. In some instances, acceptor module 102 may include acomputer processor.

Operation 404 illustrates accepting at least one physical symptomassociated with the at least one individual. For example, as shown inFIG. 1, acceptor module 102 may accept at least one physical symptomassociated with the at least one individual. In one example, acceptormodule 102 can accept from a user 118 and/or user interface 116 aphysical symptom including an indication of influenza such as a feverassociated with an individual named Mark White. A physical symptom mayinclude a manifestation, sign, and/or an indication of the presence of adisease and/or some other bodily disorder and/or abnormality. Someexamples of a physical symptom may include pain, swelling, fever, rash,and/or discoloration. In some instances, acceptor module 102 may includea computer processor.

Operation 406 illustrates accepting at least one of an indication or ameasurement of at least one of pain, hypertension, sweating, dizziness,lightheadedness, abnormal respiration, headache, fatigue, nausea, fever,abnormal heart rhythm, motor weakness, or abnormal heart rate. Forexample, as shown in FIG. 1, acceptor module 102 may accept from atleast one of an indication or a measurement of at least one of pain,high blood pressure, sweating, dizziness, lightheadedness, abnormalrespiration, headache, fatigue, nausea, fever, abnormal heart rhythm,motor weakness, or abnormal heart rate. In one example, acceptor module102 can accept an indication of pain and a measurement of high bloodpressure from network storage 110. Pain may include a sensation ofsomatic hurt or disorder and may include acute pain and/or chronic pain.Hypertension may include chronically elevated blood pressure and may beconsidered to be present when a person's systolic blood pressure isconsistently about 140 mm Hg or greater and/or their diastolic bloodpressure is consistently about 90 mm Hg or greater. Sweating may includethe excessive production and/or evaporation of fluid excreted by thesweat glands in the skin. Dizziness may include vertigo, disequilibrium,pre-syncope, and/or other balance disorders. Lightheadedness may includea sensation of dizziness and/or fainting. Abnormal respiration mayinclude atypical and/or pathological breathing patterns. Headache mayinclude pain in the head, neck, and/or upper back and may be a symptomof tension, migraine, dehydration, eye strain, sinus disorders, and/orlow blood sugar. Fatigue may include muscle weakness and/or lack ofstrength. Nausea may include the sensation of unease and/or discomfortin the stomach, often with the urge to vomit. Fever may include anincrease in internal body temperature to levels above normal. Abnormalheart rhythm may include inconsistent and/or irregular rhythmiccontractions in the heart such as sick sinus syndrome, atrialfibrillation, and/or atrial flutter. Motor weakness may include a lackof strength and/or function in the portion of the central nervous systeminvolved in movement. An abnormal heart rate may include an irregularheart contraction frequency such as bradycardia, tachycardia or thelike. In some instances, acceptor module 102 may include a computerprocessor.

FIG. 5 illustrates alternative embodiments of the example operationalflow 200 of FIG. 2. FIG. 5 illustrates example embodiments where theoperation 210 may include at least one additional operation. Additionaloperations may include an operation 502, and/or an operation 504.Further, operation 502 illustrates accepting at least one physicalimpairment associated with the at least one individual. For example, asshown in FIG. 1, acceptor module 102 may accept at least one physicalimpairment associated with the at least one individual from a user 118and a user interface 116. In one instance, acceptor module 102 accepts aphysical impairment including a bodily impairment associated with anindividual named Fred Johnson from a user 118 and/or a user interface116. A physical impairment may include a condition or function judged tobe significantly impaired relative to the usual standard of anindividual of their group and may include physical impairment, sensoryimpairment, and/or disease. In some instances, acceptor module 102 mayinclude a computer processor.

Operation 504 illustrates accepting at least one of a disease, anillness, or a bodily impairment. For example, as shown in FIG. 1,acceptor module 102 may accept at least one of a disease, an illness, ora bodily impairment. In one example, acceptor module 102 accepts anindication of a disease and a bodily impairment from database entry 114.A disease may include an abnormal condition of an organism that impairsbodily functions associated with one or more specific symptoms and signsand may include discomfort, distress, dysfunction, injury, a disorder, asyndrome, infection, and/or other atypical variation associated withstructure and/or function of the body. An illness may include any stateof poor health. Some examples of an illness may include cancer, thecommon cold, influenza, pneumonia, and/or high cholesterol. A bodilyimpairment may include a diminished ability in body function and/orstructure. In some instances, acceptor module 102 may include a computerprocessor.

FIG. 6 illustrates alternative embodiments of the example operationalflow 200 of FIG. 2. FIG. 6 illustrates example embodiments whereoperation 210 may include at least one additional operation. Additionaloperations may include an operation 602. Operation 602 illustratesaccepting an impairment associated with at least one individualincluding at least one of a potential medication reaction or a potentialsusceptibility to a side effect. For example, as shown in FIG. 1,acceptor module 102 may accept an impairment associated with at leastone individual including at least one of a potential medication reactionor a potential susceptibility to a side effect. In one example, acceptormodule 102 can accept from network storage 110 an impairment associatedwith at least one individual including at least one of a potentialmedication reaction or a potential susceptibility to a side effect. Apotential medication reaction may include a possible response a personmay exhibit resulting from at least one drug and/or medicationadministered to the person. A potential medication reaction may includean allergy and/or a drug and/or medication interaction with a separatedrug and/or medication. A potential susceptibility to a side effect mayinclude the probability a certain person may be vulnerable to a sideeffect coupled with a specific drug and/or medication. In someinstances, acceptor module 102 may include a computer processor.

FIG. 7 illustrates alternative embodiments of the example operationalflow 200 of FIG. 2. FIG. 7 illustrates example embodiments where theoperation 210 may include at least one additional operation. Additionaloperations may include an operation 702, and/or an operation 704.Further, operation 702 illustrates accepting at least one physicaldiagnosis associated with the at least one individual. For example, asshown in FIG. 1, acceptor module 102 may accept at least one physicaldiagnosis associated with the at least one individual. In a specificexample, acceptor module 102 accepts from memory device 112 a physicaldiagnosis associated with a group of ten individuals. A physicaldiagnosis may include identifying a disease and/or condition by itsoutward signs and/or symptoms. Some examples of a physical diagnosis mayinclude identifying influenza and/or identifying Alzheimer's disease. Insome instances, acceptor module 102 may include a computer processor.

Operation 704 illustrates accepting at least one diagnosis of at leastone of a cardiovascular disorder, a digestive disorder, an endocrinedisorder, a hearing disorder, an immune disorder, an inner ear disorder,an integumentary disorder, a lymphatic disorder, a muscular disorder, anervous system disorder, a reproductive disorder, a respiratorydisorder, a skeletal disorder, a visual disorder, or an urinarydisorder. For example, as shown in FIG. 1, acceptor module 102 mayaccept at least one diagnosis of at least one of a cardiovasculardisorder, a digestive disorder, an endocrine disorder, an integumentarydisorder, a lymphatic disorder, a muscular disorder, a nervous systemdisorder, a reproductive disorder, a respiratory disorder, a skeletaldisorder, or an urinary disorder. In a specific instance, acceptormodule 102 can accept from user interface 116 and/or user 118 adiagnosis of a respiratory disorder. A cardiovascular disorder mayinclude a disorder associated with the circulatory system including thepumping and channeling of blood to and from the body and lungs with theheart, the blood, and the blood vessels. Examples of a circulatorydisorder include high blood pressure, coronary heart disease,atherosclerosis, or the like. A digestive disorder may include adisorder associated with the esophagus, the stomach, the liver, thegallbladder, the pancreas, the intestines, the rectum, the anus, and/orthe digestive system including digestion and processing food withsalivary glands. Examples of a digestive disorder include GERD, Crohn'sdisease, IBS, stomach ulcers including those associated with H. pyloriinfection, or the like. An endocrine disorder may include a disorderassociated with the endocrine system including the pancreas, thepituitary gland, the pineal body and/or the pineal gland, the thyroid,the parathyroids, the adrenal glands, and/or communication within thebody using hormones made by the endocrine glands, such as thehypothalamus. Examples of an endocrine disorder include diabetes,acromegaly, or the like. A hearing disorder may include a full orpartial decrease in the ability to detect or understand sounds. Someexamples of a hearing disorder may include otosclerosis, deafness, lossdue to death of auditory hair cells, for example that caused by trauma,and/or unilateral hearing loss. An immune disorder may include adysfunction of the immune system. Examples of an immune disorder mayinclude an immunodeficiency, such as malfunctioning lymphocytes;autoimmunity, such as Coeliac disease and/or autoimmune hepatitis;and/or hypersensitivity, such as asthma. An inner ear disorder mayinclude a balance disorder, such as vertigo, disequilibrium, and/orpre-syncope. An integumentary disorder may include a disorder associatedwith the integumentary system including the skin, hair, and/or nails,such as psoriasis, eczema, dermatitis, or the like. A lymphatic disordermay include a disorder associated with the lymphatic system includingstructures involved in the transfer of lymph between tissues and theblood stream and/or the lymph and the nodes and vessels that transportlymph including the immune system, including defending againstdisease-causing agents with leukocytes, and/or including the tonsils,the adenoids, the thymus, and/or the spleen. Examples of a lymphaticdisorder include lymphedema, lymphadenopathy, or the like. A muscledisorder may include a disorder associated with the muscular systemincluding the structure and/or movement of muscles. Examples of a muscledisorder include muscular dystrophy, myasthenia gravis, an injury, suchas a strain, or the like. A nervous system disorder may include adisorder associated with the nervous system including collecting,transferring, and/or processing information with the brain, the spinalcord, the peripheral nerves, and/or the nerves. Examples of a nervoussystem disorder include multiple sclerosis, fibromyalgia, carpal tunnelsyndrome, or the like. A reproductive disorder may include a disorderassociated with the reproductive system including the sex organs, suchas ovaries, fallopian tubes, the uterus, the vagina, mammary glands,testes, the vas deferens, seminal vesicles, the prostate, and/or thepenis. Examples of a reproductive disorder include erectile dysfunction,endometriosis, fibroids, or the like. A respiratory disorder may includea disorder associated with the respiratory system including the organsused for breathing, the pharynx, the larynx, the trachea, the bronchi,the lungs, and/or the diaphragm. Examples of a respiratory disorderinclude emphysema, asthma, or the like. A skeletal disorder may includea disorder associated with the skeletal system including the structuralsupport and protection with bones, cartilage, ligaments, and/or tendons.Examples of a skeletal disorder include osteoporosis, arthritis,tendonitis, a skeletal injury, such as a bone fracture, or the like. Avisual disorder may include a disease, impairment, and/or tack offunction in the eye and/or in visual perception. Some examples of avisual disorder may include amblyopia, macular degeneration, glaucoma,and/or blindness. A urinary disorder may include a disorder associatedwith the urinary system including the kidneys, the ureters, the bladderand/or urethra involved in fluid balance, electrolyte balance and/or theexcretion of urine. Examples of a urinary disorder include bladderdysfunction, kidney disease, bladder or urethra infection, or the like.In some instances, acceptor module 102 may include a computer processor.

FIG. 8 illustrates alternative embodiments of the example operationalflow 200 of FIG. 2. FIG. 8 illustrates example embodiments where theoperation 210 may include at least one additional operation. Additionaloperations may include an operation 802, an operation 804, an operation806, and/or operation 808.

Operation 802 illustrates accepting at least one of a current treatmentor a proposed treatment associated with the at least one individual. Forexample, as shown in FIG. 1, acceptor module 102 may accept at least oneof a current treatment or a proposed treatment associated with the atleast one individual. In one instance, acceptor module 102 accepts acurrent treatment regime associated with an individual named CathyHansen. A current treatment may include one or a series of treatmentsrecommended, administered, and/or prescribed for a certain individual. Aproposed treatment may include one or a series of treatmentsrecommended, prescribed, and/or not currently administered to a certainindividual. In some instances, acceptor module 102 may include acomputer processor.

Operation 804 illustrates accepting the at least one attribute from amedical history associated with the at least one individual. Forexample, as shown in FIG. 1, acceptor module 102 may accept the at leastone attribute from a medical history associated with the at least oneindividual. In one example, acceptor module 102 may accept from databaseentry 114 an attribute 120 from a medical history including the numberof blood relatives with diabetes associated with an individual namedEmily Smith. A medical history may include a list of previous illnesses,symptoms, medicines, treatments, health risk factors, operations, and/ordoctor visits for an individual and/or a relation of an individual. Insome instances, acceptor module 102 may include a computer processor.

Operation 806 illustrates accepting the at least one attribute from apersonal medical history associated with at least one individual. Forexample, as shown in FIG. 1, acceptor module 102 may accept the at leastone attribute from a personal medical history associated with at leastone individual. In a specific instance, acceptor module 102 can acceptfrom database entry 114 an attribute 120 including, for example, a listof operations from a personal medical history associated with anindividual named Robert Murphy. A personal medical history may include alist of previous illnesses, symptoms, medicines, treatments, health riskfactors, operations, and/or doctor visits associated with at least oneindividual. A personal and/or a family medical history may include lifehistory and/or social history characteristics such as smoking, drinking,drug use, sexual history, exercise history, eating history,nutraceutical history, or the like. In some instances, acceptor module102 may include a computer processor.

Operation 808 illustrates accepting the at least one attribute from afamily medical history associated with the at least one individual. Forexample, as shown in FIG. 1, acceptor module 102 may accept the at leastone attribute from a family medical history associated with the at leastone individual. In one example, acceptor module 102 can accept fromnetwork storage 110 an attribute 120 including a list of family membersthat have had ovarian cancer from a family medical history associatedwith an anonymous individual or an individual named Elizabeth Green. Afamily medical history may include a list of previous illnesses,symptoms, medicines, treatments, health risk factors, operations, and/ordoctor visits associated with family members related to the at least oneindividual. In some instances, acceptor module 102 may include acomputer processor.

FIG. 9 illustrates alternative embodiments of the example operationalflow 200 of FIG. 2. FIG. 9 illustrates example embodiments whereoperation 210 may include at least one additional operation. Additionaloperations may include an operation 902.

Operation 902 illustrates accepting at least one mental enhancement goalassociated with the at least one individual. For example, as shown inFIG. 1, acceptor module 102 may accept at least one mental enhancementgoal associated with the at least one individual. In one instance,acceptor module 102 can accept a mental enhancement goal associatedwith, for example, an individual named Dorothy Anderson. A mentalenhancement goal may include a mental state and/or situation anindividual may plan to achieve. Some examples of a mental enhancementgoal may include achieving a certain state of mental awareness such asincreased alertness or visual perception, reaching a certain cognitivecapability such as enhanced memory or pattern recognition, maintaining aspecific attention level, and/or reducing or eliminating a phobia. Insome instances, acceptor module 102 may include a computer processor.

FIG. 10 illustrates alternative embodiments of the example operationalflow 200 of FIG. 2. FIG. 10 illustrates example embodiments whereoperation 210 may include at least one additional operation. Additionaloperations may include an operation 1002, an operation 1004, and/or anoperation 1006.

Operation 1002 illustrates accepting at least one mental attributeassociated with the at least one individual. For example, as shown inFIG. 1, acceptor module 102 may accept at least one mental attributeassociated with the at least one individual. In one example, acceptormodule 102 can accept a mental attribute 120 including, for example, anintelligence quotient associated with an individual named Judy Peterson.A mental attribute may include an attribute that may be related toand/or associated with basic mental function and/or high-level brainfunction. Some examples of a mental attribute may include anintelligence quotient (IQ), measurements of brain activity for exampleusing functional MRI or near infra-red technology, and/or measurementsof mental development. In some instances, acceptor module 102 mayinclude a computer processor.

Operation 1004 illustrates accepting at least one mental symptomassociated with the at least one individual. For example, as shown inFIG. 1, acceptor module 102 may accept at least one mental symptomassociated with the at least one individual. In one example, acceptormodule 102 can accept from network storage 110 a mental symptomincluding a stress level measurement associated with an individual namedHeather Swanson. A mental symptom may include a manifestation, sign,and/or an indication of the presence of a disease and/or some othermental disorder and/or abnormality. Some examples of a mental symptommay include lack of attention, indication of stress, hyperactivity,nervousness, and/or lack of responsiveness. In some instances, acceptormodule 102 may include a computer processor.

Operation 1006 illustrates accepting at least one indication of anxiety,an appearance, a behavior, depression, fear, inattention, a mooddisturbance, a phobia, or a psychological test result. For example, asshown in FIG. 1, acceptor module 102 may accept at least one indicationof anxiety, appearance, behavior, depression, fear, inattention, mooddisturbance, phobia, or psychological test result. In one example,acceptor module 102 can accept from user interface 116 and user 118 anindication of anxiety and depression. Anxiety may include feelings offear, apprehension, and/or worry and may be accompanied by physicalsensations. An appearance may include an outward, audible, and/orvisible aspect of a person and/or thing associated with a person. Abehavior may include the manner in which a person and/or thingassociated with a person acts and/or reacts. Depression may include amental state characterized by pessimism, a sense of inadequacy,despondence, despair, a low level of energy, and/or a lack of activity.Fear may be caused by impending danger, perceived evil, and/or pain,whether real or imagined. Inattention may include the failure of aperson to focus attention. A mood disturbance may include a change inemotional state. A phobia may include an irrational, and/or persistentfear of certain situations, objects, activities, and/or people. Apsychological test result may include a sample behavior for inferring acertain generalization about a person. For example, a personality testresult may indicate that person has obsessive/compulsivecharacteristics. In some instances, acceptor module 102 may include acomputer processor.

FIG. 11 illustrates alternative embodiments of the example operationalflow 200 of FIG. 2. FIG. 11 illustrates example embodiments whereoperation 210 may include at least one additional operation. Additionaloperations may include an operation 1102.

Operation 1102 illustrates accepting at least one measurement associatedwith at least one of brain activity, cardiac activity, vascularactivity, peripheral neural signals, hemodynamic activity, or metabolicactivity. For example, as shown in FIG. 1, acceptor module 102 mayaccept at least one measurement associated with at least one of brainactivity, cardiac activity, vascular activity, peripheral neuralsignals, hemodynamic activity, or metabolic activity. In one instance,acceptor module 102 can accept from database entry 114 a measurementassociated with brain activity. Brain activity may include theelectrical activity of the brain, such as that measured by EEG, MEG, orthe like. Other brain activity measurements may include functional MRIimaging, near infra-red imaging, PET scanning, or the like. Cardiacactivity may include electrical activity in the heart, such as thatmeasured by EKG or visual imaging. Vascular activity may include anyactivity and/or function of the circulatory system. Peripheral neuralsignals may include neural signals sent through the peripheral nervoussystem. Hemodynamic activity may include any activity associated withthe circulatory system. Metabolic activity may include any activityassociated with the biochemical reactions occurring in a livingorganism. In some instances, acceptor module 102 may include a computerprocessor.

FIG. 12 illustrates alternative embodiments of the example operationalflow 200 of FIG. 2. FIG. 12 illustrates example embodiments whereoperation 210 may include at least one additional operation. Additionaloperations may include an operation 1202, and/or an operation 1204.

Operation 1202 illustrates accepting at least one mental impairmentassociated with at least one individual. For example, as shown in FIG.1, acceptor module 102 may accept at least one mental impairmentassociated with at least one individual. In one example, acceptor module102 can accept from memory device 112 a mental impairment associatedwith an individual named Richard Lewis. A mental impairment may includea condition or function judged by a health care provider to besignificantly impaired relative to the usual standard of an individualof their group, and may include mental impairment, sensory impairment,and/or mental disease. In some instances, acceptor module 102 mayinclude a computer processor.

Operation 1204 illustrates accepting at least one indication of at leastone of a mood disorder, an anxiety disorder, a psychotic disorder, aneating disorder, a developmental disorder, a phobia, a communicationdisorder, a social disorder, or a personality disorder. For example, asshown in FIG. 1, acceptor module 102 may accept at least one indicationof at least one of a mood disorder, an anxiety disorder, a psychoticdisorder, an eating disorder, a developmental disorder, a phobia, or apersonality disorder. In one instance, acceptor module 102 can acceptfrom user interface 116 and/or user 118 an indication of a mood disorderincluding a mood change and the onset of depression in a specificindividual. A mood disorder may include a condition whereby theprevailing emotional mood is distorted or inappropriate to thecircumstances, and may include examples such as bipolar disorder, analteration in mood, and/or depression. An anxiety disorder may includenervous system disorders such as irrationality, illogical worry notbased on fact, fear, and/or phobia. A psychotic disorder may include astate of mind in which thinking becomes irrational and/or disturbed andmay include hallucinations, abnormal perception, mania, dementia,delusions and/or delusional beliefs, delirium, depression, psychosispersonality disorder, personality changes, and/or disorganized thinking.An eating disorder may include a compulsion to eat and/or avoid eatingthat negatively affects physical and/or mental health. Some examples ofan eating disorder may include anorexia nervosa and bulimia nervosa. Adevelopmental disorder may include a disorder occurring in a child'sdevelopment, which may retard development. Some examples of adevelopmental disorder may include an emotional disorder, a cognitivedisorder, and/or a mental disorder accompanied by physical traits, suchas Down syndrome. A phobia may include an irrational, intense, and/orpersistent fear of certain situations, objects, activities, and/orpersons. Examples of phobias include social phobias, arachnophobia,xenophobia, and/or claustrophobia. A communication disorder may includea disease and/or a condition partially or totally preventing humancommunication. Some examples of a communication disorder may includeautism, stuttering, and/or aphasia. A social disorder may include acondition characterized by a difficulty in human interaction and/oremotional discomfort in social situations. Some examples of a socialdisorder may include stage fright, social anxiety disorder, and/orshyness. A personality disorder may include a disorder characterized bypathological trends in personality structure. Some examples of apersonality disorder may include a paranoid personality disorder, anarcissistic personality disorder, and/or an obsessive-compulsivepersonality disorder. In some instances, acceptor module 102 may includea computer processor.

FIG. 13 illustrates alternative embodiments of the example operationalflow 200 of FIG. 2. FIG. 13 illustrates example embodiments whereoperation 210 may include at least one additional operation. Additionaloperations may include an operation 1302, and/or an operation 1304.Further, operation 1302 illustrates accepting at least one mentaldiagnosis associated with at least one individual. For example, as shownin FIG. 1, acceptor module 102 may accept at least one mental diagnosisassociated with at least one individual. In a specific instance,acceptor module 102 accepts from memory device 112 a mental diagnosisincluding a phobia associated with an anonymous individual or anindividual named Roy Black. A mental diagnosis may include identifying amental disorder and/or condition by its symptoms. Some examples of amental diagnosis may include a mood disorder such as depression, ananxiety disorder such as PTSD, a behavioral disorder such as ADHD, apersonality disorder such as borderline personality disorder, and/or aphobia. Mental disorders may include those listed in the Diagnostic andStatistical Manual of Mental Disorders (DSM). In some instances,acceptor module 102 may include a computer processor.

Operation 1304 illustrates accepting at least one of a depression, aphobia, an anxiety disorder, a personality disorder, a psychoticdisorder, a developmental disorder, a panic disorder, a bipolardisorder, schizophrenia, an eating disorder, obsessive compulsivedisorder, post traumatic stress disorder, an attentional disorder, acommunication disorder, a social disorder, or a mood disorder. Forexample, as shown in FIG. 1, acceptor module 102 may accept at least oneof a depression, a phobia, an anxiety disorder, a personality disorder,a psychotic disorder, a developmental disorder, a panic disorder, or amood disorder. In one example, acceptor module 102 accepts from databaseentry 114 a diagnosis of depression. Depression may include a mentalstate characterized by a pessimistic sense of inadequacy and/or adespondent lack of activity. A phobia may include an irrational,intense, and/or persistent fear of certain situations, objects,activities, and/or persons. Some phobias may include social phobias,arachnophobia, xenophobia, and/or claustrophobia. An anxiety disordermay include nervous system disorders such as irrationality, illogicalworry not based on fact, fears, and/or phobias. A personality disordermay include a disorder characterized by pathological trends inpersonality structure. Some examples of a personality disorder mayinclude a paranoid personality disorder, a narcissistic personalitydisorder, and/or an obsessive-compulsive personality disorder. Apsychotic disorder may include a state of mind in which thinking becomesirrational and/or disturbed and may include hallucinations, delusionalbeliefs, personality changes, and/or disorganized thinking. Adevelopmental disorder may include a disorder occurring in a child'sdevelopment, which may often retard development. Some examples of adevelopmental disorder may include psychological or physical disorders.A panic disorder may include a condition characterized by recurringpanic attacks in combination with significant behavioral change. Abipolar disorder may include a mood disorder characterized by thepresence of one or more episodes of abnormally elevated mood, such asBipolar I disorder, Bipolar II disorder, cyclothymia, and/orBipolar-NOS. Schizophrenia may include a mental illness characterized byimpairments in the perception or expression of reality, most commonlymanifesting as auditory hallucinations, paranoid or bizarre delusions ordisorganized speech and thinking in the context of significant social oroccupational dysfunction. An eating disorder may include a compulsion toeat or avoid eating, such as anorexia nervosa and/or bulimia nervosa.Obsessive compulsive disorder may include a psychiatric anxiety disordercharacterized by obsessive, distressing, intrusive thoughts and relatedcompulsions which attempt to neutralize the obsessions. Post traumaticstress disorder may include an anxiety disorder that can develop afterexposure to one or more terrifying events in which grave physical harmoccurred or was threatened. An attentional disorder may include apersistent pattern of inattention and/or hyperactivity, as well asforgetfulness, poor impulse control or impulsivity, and distractibility,such as attention-deficit hyperactivity disorder (ADHD). A communicationdisorder may include a disease and/or a condition partially or totallypreventing human communication. Some examples of a communicationdisorder may include autism, stuttering, and/or aphasia. A socialdisorder may include a condition characterized by a difficulty in humaninteraction and/or emotional discomfort in social situations. Someexamples of a social disorder may include stage fright, social anxietydisorder, and/or shyness. A mood disorder may include a conditionwhereby the prevailing emotional mood is distorted or inappropriate tothe circumstances and may include examples such as bipolar disorderand/or depression. In some instances, acceptor module 102 may include acomputer processor.

FIG. 14 illustrates alternative embodiments of the example operationalflow 200 of FIG. 2. FIG. 14 illustrates example embodiments whereoperation 210 may include at least one additional operation. Additionaloperations may include an operation 1402. Further, operation 1402illustrates accepting at least one past mental therapy associated withthe at least one individual. For example, as shown in FIG. 1, acceptormodule 102 may accept at least one past mental therapy associated withthe at least one individual. In one instance, acceptor module 102 canaccept from database entry 114 a past mental therapy associated with anindividual named James Williams or an anonymous individual. A pastmental therapy may include a list and/or a record of at least one mentaltherapy, such as an anti-depressant medication, administered to at leastone individual. In some instances, acceptor module 102 may include acomputer processor.

FIG. 15 illustrates alternative embodiments of the example operationalflow 200 of FIG. 2. FIG. 15 illustrates example embodiments whereoperation 210 may include at least one additional operation. Additionaloperations may include an operation 1502, an operation 1504, and/or anoperation 1506.

Operation 1502 illustrates accepting the at least one attributeassociated with the at least one individual from a health care provider.For example, as shown in FIG. 1, acceptor module 102 may accept the atleast one attribute associated with the at least one individual from ahealth care provider. In one example, acceptor module 102 can acceptfrom user interface 116 and/or user 118 an attribute 120 including amedication history associated with a group of fifty individuals from ahealth care provider 136. A health care provider may include a hospital,a doctor, a nurse, a medical clinic, a dentist, and/or any provider ofpreventive, diagnostic, therapeutic, rehabilitative, maintenance, orpalliative care and/or counseling. A healthcare provider may include aseller and/or dispenser of prescription drugs or medical devices. Insome instances, acceptor module 102 may include a computer processor.

Operation 1504 illustrates accepting the at least one attributeassociated with the at least one individual from a licensed health careprovider. For example, as shown in FIG. 1, acceptor module 102 mayaccept the at least one attribute associated with the at least oneindividual from a licensed health care provider. In one instance,acceptor module 102 accepts from memory device 112 an attribute 120including a symptom indication a phobia associated with an individualnamed Robert Clark from a licensed health care provider 136. A licensedhealth care provider may include a person licensed by a governingauthority, such as a state, to provide medical and/or health care. Someexamples of a licensed health care provider may include a licensedmedical doctor or physician, a licensed physician's assistant, and/or alicensed nurse practitioner. In some instances, acceptor module 102 mayinclude a computer processor.

Operation 1506 illustrates accepting the at least one attributeassociated with the at least one individual from an alternative medicineprovider. For example, as shown in FIG. 1, acceptor module 102 mayaccept the at least one attribute associated with the at least oneindividual from an alternative medicine provider. In one instance,acceptor module 102 can accept from network storage 110 an attribute 120associated with an individual named Connie Martin from an alternativemedicine provider. An alternative medicine provider may include aprovider of folk medicine, herbal medicine, diet fads, homeopathy, faithhealing, new age healing, chiropractic, acupuncture, aromatherapy,naturopathy, massage, reflexology, hypnotism, and/or music therapy. Insome instances, acceptor module 102 may include a computer processor.

FIG. 16 illustrates alternative embodiments of the example operationalflow 200 of FIG. 2. FIG. 16 illustrates example embodiments whereoperation 220 may include at least one additional operation. Additionaloperations may include an operation 1602.

Operation 1602 illustrates searching at least one prescriptionmedication database and at least one artificial sensory experiencedatabase. For example, as shown in FIG. 1, querier module 104 may searchat least one prescription medication database and at least oneartificial sensory experience database. In one example, querier module104 searches a medication database 124 and an artificial sensoryexperience database 126. A database may include a collection of dataorganized for convenient access. The database may include informationdigitally stored in a memory device 112, as at least a portion of atleast one database entry 114, and/or in network storage 110. In someinstances, the database may include information stored non-digitallysuch as at least a portion of a book, a paper file, and/or anon-computerized index and/or catalog. Non-computerized information maybe received by acceptor module 102 by scanning or by manually enteringthe information into a digital format. A prescription database and/ormedication database may include any database associated with at leastone prescription medication and may be available to health careprofessionals and/or the public. An artificial sensory experiencedatabase may include any database associated with at least oneartificial sensory experience and may include a database accessible bythe public and/or a health care provider. In some instances, acceptormodule 102 and/or querier module 104 may include one or more computerprocessors.

FIG. 17 illustrates alternative embodiments of the example operationalflow 200 of FIG. 2. FIG. 17 illustrates example embodiments whereoperation 230 may include at least one additional operation. Additionaloperations may include an operation 1702, and/or an operation 1704.

Operation 1702 illustrates selecting the at least one prescriptionmedication from a physician's desk reference database. For example, asshown in FIG. 1, selector module 106 may select the at least oneprescription medication from a physician's desk reference database. Inone example, selector module 106 selects the at least one prescriptionmedication from a physician's desk reference database 122, such as a PDRpsychiatry database. In some instances, selector module 106 may includea computer processor.

Operation 1704 illustrates selecting at least one of an analgesic, anantacid, an antiarrhythmic, an antibacterial, an antibiotic, ananticoagulant, a thrombolytic, an anticonvulsant, an antidiarrheal, anantiemetic, an antifungal, an anti-allergic agent, an antihistamine, anantihypertensive, an anti-anginal, an anti-asthmatic, ananti-inflammatory, an antineoplastic, an antipyretic, an antiviral, ananti-ulcer agent, an antidyspeptic, an antacid, a beta-blocker, abronchodilator, a cold treatment, a corticosteroid, an antitussive, acytotoxic agent, a decongestant, a diuretic, an expectorant, a hormone,a hypoglycemic, an immunosuppressive, a laxative, a muscle relaxant, asedative, a female sex hormone, a male sex hormone, a tranquilizer, anappetite modulator, or a vitamin. For example, as shown in FIG. 1,selector module 106 may select at least one of an analgesic, an antacid,an antiarrhythmic, an antibacterial, an antibiotic, an anticoagulant, athrombolytic, an anticonvulsant, an antidiarrheal, an antiemetic, anantifungal, an anti-allergic agent, an antihistamine, anantihypertensive, an anti-anginal, an anti-asthmatic, ananti-inflammatory, an antineoplastic, an antipyretic, an antiviral, ananti-ulcer agent, an antidyspeptic, an antacid, a beta-blocker, abronchodilator, a cold treatment, a corticosteroid, a cough suppressant,an antitussive, a cytotoxic agent, a decongestant, a diuretic, anexpectorant, a hormone, a hypoglycemic, an immunosuppressive, alaxative, a muscle relaxant, a sedative, a female sex hormone, a matesex hormone, a tranquilizer, an appetite modulator, or a vitamin. Ananalgesic may include a drug and/or other medication suitable forrelieving pain. Additionally, an analgesic may be effective forrelieving different degrees of pain. Some examples of an analgesic mayinclude narcotics such as morphine or oxycodone, non-narcotics, an NSAIDsuch as aspirin or naproxen or ibuprofen, and/or acetaminophen. Anantacid may include a substance for neutralizing stomach acid, such as aproton pump inhibitor. Some examples of an antacid may includeimeprazole and/or a pharmaceutical composition containing aluminumhydroxide, magnesium hydroxide, aluminum carbonate, calcium carbonate,sodium bicarbonate, hydrotalcite, bismuth subsalicylate, magaldrate,and/or simethicone.

An antiarrhythmic may include a drug for controlling a heartbeatirregularity. Some examples of an antiarrhythmic may include a betablocker such as propanolol, and/or lidocaine, verapamit, and/orquinidine. An antibacterial may include a drug used to treat aninfection. Some examples of an antibacterial may include amoxicillinand/or ciprofloxacin. An antibiotic may include a drug made fromnaturally occurring and/or synthetic substances for combating abacterial infection. Some examples of an antibiotic may includepenicillin, streptomycin, and/or sulfonamide-based drugs. Ananticoagulant may include an agent for preventing blood clots. Anexample of an anticoagulant may include a vitamin K antagonist, such aswarfarin, and/or aspirin. A thrombolytic may help dissolve and dispersea blood clot and may be prescribed for patients with recent arterial orvenous thrombosis. A thrombolytic may be derived from Streptomyces spp.and/or recombinant DNA technology and may include streptokinase,urokinase, and/or a tissue plasminogen activator (TPA) such asalteplase.

An anticonvulsant may include a pharmaceutical administered for theprevention of seizures. Some examples of an anticonvulsant may include abarbiturate, a carbamate, a fatty acid derivative, and/or a sulfonamide.An antidiarrheat may include a drug utilized for the relief of diarrhea.Some examples of an antidiarrheat may include an antispasmodic such asdiphenoxylate and loperamide, a bismuth compound, a bulking agent,and/or an absorbent. An antiemetic may include a drug used to treatnausea and vomiting. Some examples of an antiemetic may include a 5-HT3receptor antagonist, a dopamine antagonist, and/or a histamine. Anantifungal may include a drug used to treat fungal infections, the mostcommon of which affect the hair, skin, nails, and/or mucous membranes.Some examples of antifungals may include polyene antifungals, imidazoleand triazole antifungals, and/or allylamines. An anti-allergenic agentmay include an agent characterized by preventing and/or reducing theeffect of an allergen. Some examples of an anti-allergenic may includean antihistamine, cortisone, hydrocortisone, and/or epinephrine. Anantihistamine may include an agent used for counteracting the effects ofhistamine. Some examples of an antihistamine may include a H1-receptorantagonist and/or a H2-receptor antagonist. An antihypertensive mayinclude drugs utilized for lowering blood pressure. Some examples of anantihypertensive may include a diuretic, an adrenergic receptorantagonist, and/or an ACE inhibitor. An anti-anginal may include anagent used for preventing and/or reducing angina and/or chest pain. Someexamples of an anti-anginal may include aspirin, ranolazine, and/orivabradine. An anti-asthmatic may include an agent for preventing and/orreducing asthma and/or its effects. Some examples of an anti-asthmaticmay include albuterol, an inhaled steroid, for example budesonide orfluticasone, and/or ipratropium bromide.

An anti-inflammatory may include an agent utilized to reduceinflammation and/or to treat redness, heat, swelling, and/or increasedblood flow associated for example, that seen with an infection orinjury, or in many chronic diseases such as rheumatoid arthritis andgout. Some anti-inflammatories may include steroids, and/or NSAIDs suchas naproxen, ibuprofen, and/or aspirin. An antineoplastic may includedrugs used to treat cancer and to inhibit and/or prevent the developmentof tumors. Some antineoplastics may include alkylating agents,antimetabolites, enzymes, enzyme inhibitors, immune modulators, andtaxoids. An antipyretic may include a drug used to reduce a fever. Someexamples of an antipyretic may include aspirin and/or acetaminophen. Anantiviral may include a drug used to treat viral infections and/or toprovide temporary protection against viral infections such as influenza.Some examples of an antiviral may include an interferon, acyclovir,ribavirin, and/or oseltamivir. An anti-ulcer agent may include an agentused for preventing and/or lessening the effect of an ulcer, includingstomach ulcers, mouth ulcers, or other types of ulcers. Some examples ofan anti-ulcer agent may include a bismuth compound, a prostaglandinanalogue, and/or cimetidine. An antidyspeptic may include an agent usedfor treating and/or preventing dyspepsia. Some examples of anantidyspeptic may include simethicone and/or a proton pump inhibitor,such as esomeprazole. An antacid may include a substance, often a base,which may counteract stomach acidity. Some examples of an antacid mayinclude magnesium hydroxide, aluminum hydroxide, calcium carbonate,and/or bismuth subsalicylate. A beta-blocker may include abeta-adrenergic blocking agent utilized for reducing the oxygen needs ofthe heart by reducing the heartbeat rate. Some examples of abeta-blocker may include propranolol, esmolol, bisoprolol, and/ortimolol. A bronchodilator may include an agent utilized for opening thebronchial tubes within the lungs when the tubes have become narrowed,for example, by muscle spasm and may be used for treating asthma. Someexamples of a bronchodilator may include albuterol and/or ipratropiumbromide. A cold treatment may include an agent utilized for treatingaches, pains, and/or fever accompanying a cold. Some cold treatments mayinclude aspirin, acetaminophen, a decongestant, an antihistamine, and/orcaffeine.

A corticosteroid may include a hormonal preparation used as ananti-inflammatory for arthritis or asthma and/or treating somemalignancies or compensating for a deficiency of natural hormones. Someexamples of a corticosteroid may include cortisol and/or aldosterone. Acough suppressant may include an agent used to soothe irritation causedby coughing and/or to prevent coughing. Some examples of a coughsuppressant may include codeine, an antihistamine, and/ordextromethorphan. An antitussive may include a cough suppressant. Acytotoxic agent may include a drug used for killing and/or damagingcells. Some examples of a cytotoxic agent may include actinomycin-D,azathioprine, bleomycin, melphalan, busulphan, doxorubicin, etoposide,an antineoplastic agent, and/or an apoptotic agent. A decongestant mayinclude an agent for reducing the swelling of the mucous membraneslining the nose and/or throat. Some examples of a decongestant mayinclude pseudoephedrine and phenylephrine. A diuretic may include anagent for increasing the quantity of urine produced by the kidneys andpassed out of the body. Some examples of a diuretic may includehydrochlorothiazide, spironolactone, mannitol, and/or glucose. Anexpectorant may include an agent for stimulating the flow of saliva,loosening and thinning mucus in airways, and/or promoting a moreproductive cough as to eliminate phlegm from the respiratory tract. Anexample of an expectorant may include guaifenesin. A hormone may includemolecules produced naturally by the endocrine glands. Some examples of ahormone may include steroid hormones, amine-derived hormones, peptidehormones, and/or lipid and phospholipid-derived hormones. A hypoglycemicmay include an agent for lowering the level of glucose in the blood.Some examples of a hypoglycemic may include a sulfonylurea, ameglitinide, a biguanide, a thiazolidinedione, and/or aalpha-glucosidase inhibitor. An immunosuppressive may include an agentfor preventing or reducing the body's normal reaction to invasion bydisease and/or foreign tissues. Some examples of an immunosuppressivemay include a drug such as a corticosteroid, cyclosporine, rapamycin,which acts on immunophilins, and/or an antibody.

A laxative may include an agent for increasing the frequency and ease ofbowel movements. Some examples of a laxative may includemethylcellulose, docusate, mineral oil, and/or magnesium hydroxide. Amuscle relaxant may include an agent utilized for relieving musclespasms. Some examples of a muscle relaxant may include neuromuscularblocking drugs, carisoprodol, cyclobenzaprine, metaxalone, abenzodiazepine and/or a tranquilizer. A sedative may include a substancewhich depresses the central nervous system and may result in calmness,relaxation, reduction of anxiety, sleepiness, and/or slowed breathing.Some examples of a sedative may include zolpidem, and/or eszopiclone. Afemale sex hormone may include a hormone responsible for the developmentof female secondary sexual characteristics. Some examples of a femalesex hormone may include estrogen and progesterone. A male sex hormonemay include a hormone responsible for the development of secondary malesexual characteristics. One example of a male sex hormone may includetestosterone. Sex hormone-related agents may include agentsmetabolically related to sex hormones. Examples of sex hormone-relatedagents may include sterols, androgens (testosterone), progestogensestrogens (estradiols, estrone), follicle-stimulating hormone,luteinizing hormone, inhibin B, anti-Mullerian hormone thyroid-relatedhormones. A tranquilizer may include any drug having a calming and/orsedative effect. Some examples of a tranquilizer may include anantidepressant, a barbiturate, and/or a benzodiazepine. An appetitemodulator may include an agent used for regulating and/or adjustingappetite. Some examples of an appetite modulator may include recombinantPYY 3-36 and/or sibutramine. A vitamin may include chemicals essentialin relatively small quantities for good health. Some examples of avitamin may include Vitamin A, Vitamin C, Vitamin D, and/or Vitamin K.

In one instance, selector module 106 can select an analgesic and anantipsychotic for subsequent presentation, perhaps in response toaccepting a pain symptom and a hallucination symptom as the at least oneattribute. In some instances, selector module 106 may include a computerprocessor.

FIG. 18 illustrates alternative embodiments of the example operationalflow 200 of FIG. 2. FIG. 18 illustrates example embodiments whereoperation 230 may include at least one additional operation. Additionaloperations may include an operation 1802. Further, operation 1802illustrates selecting at least one of an antiparalytic, an antimanic, anantineuralgic, an anti-dyskinesia agent, an antispasmodic, anantiadrenergic, an antimuscarinic, a neuromimetic agent, a neuromuscularagent, an antianxiety agent, an antipsychotic, an antidepressant, a moodstabilizer, a stimulant, an anxiolytic, a hypnotic, or a sleeping agent.For example, as shown in FIG. 1, selector module 106 may select at leastone of an antiparalytic, an antimanic, an antineuralgic, ananti-dyskinesia agent, an antispasmodic, an antiadrenergic, anantimuscarinic, a neuromimetic agent, a neuromuscular agent, anantianxiety drug, an antipsychotic, an antidepressant, a moodstabilizer, a stimulant, an anxiolytic, a hypnotic, and/or a sleepingagent such as a long-acting barbiturate. In one example, selector module106 selects an antianxiety drug and a sleeping agent. An antiparalyticmay include an agent used for preventing the loss of and/or recoveringmuscle function. One example of an antiparalytic may includemethylprednisolone. An antimanic may include an agent used for treatingand/or suppressing mania. Some examples may include lamotrigine and/orcarbamazepine. An antineuralgic may include an agent for relievingparoxysmal nerve pain. One example of an antineuralgic may includecarbamazepine. An anti-dyskinesia agent may include an agent used forreducing and/or preventing dyskinesia, including involuntary musclemovement. One example of an anti-dyskinesia agent may includemethylenedioxymethamphetamine. An antispasmodic may include a drug or anherb that suppresses smooth muscle contraction. Some examples of anantispasmodic may include dicyclomine and/or hyoscyamine. Anantiadrenergic may include a medication for inhibiting the functioningof the sympathetic nervous system. Some examples of an antiadrenergicmay include clonidine and/or mecamylamine. An antimuscarinic may includean agent for reducing the activity of the muscarinic acetylcholinereceptor. Some examples of an antimuscarinic may include atropine and/orhyoscine. A neuromimetic agent may include an agent that mimics theresponse of an effector organ to nerve impulses. A neuromuscular agentmay block neuromuscular transmission at the neuromuscular junction andcause paralysis of the affected skeletal muscles. Some examples of aneuromuscular agent may include atracurium and/or vecuronium. Anantianxiety drug may include a drug for suppressing anxiety and relaxingthe muscles. An antianxiety drug may include a sedative, a tranquilizer,an anxiolytic, such as a benzodiazepine, alprazolam and/or diazepam, anantidepressant, a short-acting barbiturate, and/or an herbal treatment,such as chamomile, kava extract, Kratom, and/or valerian. Anantipsychotic may include a group of drugs commonly used to treatpsychosis and may include phenothiazines, thioxanthenes, butyrophenones,risperidone, amisulpride, and/or other suitable drugs. An antidepressantmay include a psychiatric medication or other substance, such as anutrient or herb, used for alleviating depression or dysthymia. Someexamples of an antidepressant may include a selective serotonin reuptakeinhibitor, such as Prozac and/or Zoloft, and/or aserotonin-norepinephrine reuptake inhibitor, such as Cymbalta. A moodstabilizer may include a psychiatric medication used to treat mooddisorders characterized by intense and sustained mood shifts. Someexamples of a mood stabilizer may include lithium carbonate and/orlamotrigine. A stimulant may include substances that may temporarilyincrease alertness and awareness, such as caffeine, ephedrine, and/ornicotine. An anxiolytic may include a substance used for the treatmentof anxiety, such as a benzodiazepine and/or a barbiturate. A hypnoticmay include substances that induce sleep, such as a barbiturate and/oran antihistamine (diphenhydramine). A sleeping agent may include anynumber of medications for helping a person sleep and/or stay asleep andmay include benzodiazepines, antidepressants, melatonin, and/orantihistamines as well as other suitable substances. In some instances,selector module 106 may include a computer processor.

FIG. 19 illustrates alternative embodiments of the example operationalflow 200 of FIG. 2. FIG. 19 illustrates example embodiments whereoperation 230 may include at least one additional operation. Additionaloperations may include an operation 1902, an operation 1904, and/or anoperation 1906.

Operation 1902 illustrates selecting the at least one prescriptionmedication at least partially based on at least one of a behavior, asymptom, or a diagnosis. For example, as shown in FIG. 1, selectormodule 106 may select the at least one prescription medication at leastpartially based on at least one of a behavior, a symptom, or adiagnosis. In one instance, selector module 106 can select aprescription medication based on a diagnosis. A behavior may include themanner a person behaves toward other people and/or a certaincircumstance. A symptom may include a subjective indicator of a healthproblem reported by an individual, or a sign of a health problem noticedby another, perhaps a doctor. A symptom may be evidence of a disease, adisability, an impairment, and/or a condition. A diagnosis may includean identification of a disease, a disability, an impairment, and/or acondition. In some instances, selector module 106 may include a computerprocessor.

Operation 1904 illustrates selecting the at least one prescriptionmedication at least partially based on at least one of a susceptibilityto a drug side effect or a drug interaction. For example, as shown inFIG. 1, selector module 106 may select the at least one prescriptionmedication at least partially based on at least one of a susceptibilityto a drug side effect or a drug interaction. In one instance, selectormodule 106 can select a prescription medication based on asusceptibility to a drug side effect including an allergy. Asusceptibility to a drug side effect may include a probability a certainperson may be vulnerable to a side effect associated with a specificdrug and/or medication. A susceptibility to a drug side effect mayinclude predisposition to a particular drug side effect or class of drugside effects, such as upset stomach associated with aspirinformulations. A drug reaction may include a possible response a personmay exhibit resulting from at least one drug and/or medicationadministered to the person. A drug reaction may include an allergyand/or a drug and/or medication interaction with a separate drug and/ormedication. In some instances, selector module 106 may include acomputer processor.

Operation 1906 illustrates selecting a prescription medication and atleast one alternative medicine treatment as the at least oneprescription medication. For example, as shown in FIG. 1, selectormodule 106 may select a prescription medication and at least onealternative medicine treatment as the at least one prescriptionmedication. In one instance, selector module 106 can select aprescription medication and at least one alternative medicine treatmentas the at least one prescription medication. A prescription medicationmay include a medication, drug, and/or treatment available only withwritten instructions from a doctor, dentist, and/or other licensedprofessional. An alternative medicine treatment may include medicaland/or nutraceutical treatments and/or practices utilized instead ofstandard medical treatments. Some examples of alternative medicinetreatments may include chiropractic, herbal medicine, acupuncture,homeopathy, naturopathy, and/or spiritual devotions. In some instances,selector module 106 may include a computer processor.

FIG. 20 illustrates alternative embodiments of the example operationalflow 200 of FIG. 2. FIG. 20 illustrates example embodiments whereoperation 230 may include at least one additional operation. Additionaloperations may include an operation 2002, and/or an operation 2004.

Operation 2002 illustrates selecting the at least one prescriptionmedication at least partially based on at least one of a medicationhistory of the at least one individual or an artificial sensoryexperience history of the at least one individual. For example, as shownin FIG. 1, selector module 106 may select the at least one prescriptionmedication at least partially based on at least one of a medicationhistory of the at least one individual or an artificial sensoryexperience history of the at least one individual. In one example,selector module 106 can select a prescription medication based on amedication history of an individual named Jennifer Harris or ananonymous individual. A medication history may include any record ofadministered medications and/or drugs that may exist for an individual.An artificial sensory experience history may include any record of anartificial sensory experience associated with an individual. In someinstances, selector module 106 may include a computer processor.

Operation 2004 illustrates selecting the at least one prescriptionmedication at least partially based on at least one of a genetic or anepigenetic profile. For example, as shown in FIG. 1, selector module 106may select the at least one prescription medication at least partiallybased on at least one of a genetic or an epigenetic profile. In oneinstance, selector module 106 can select a prescription medication basedon a genetic profile. A genetic profile may include hereditaryinformation encoded in the genetic sequence of an individual. Anepigenetic profile may include information regarding chromatin and/orDNA modifications that are stable over rounds of cell division but donot involve changes in the underlying DNA sequence of the organism, suchas histone acetylation and/or DNA methylation. Other epigeneticinformation may be found in higher-order chromatin structure. In someinstances, selector module 106 may include a computer processor.

FIG. 21 illustrates alternative embodiments of the example operationalflow 200 of FIG. 2. FIG. 21 illustrates example embodiments whereoperation 230 may include at least one additional operation. Additionaloperations may include an operation 2102, and/or an operation 2104.

Operation 2102 illustrates selecting at least one virtual experience asthe at least one artificial sensory experience. For example, as shown inFIG. 1, selector module 106 may select at least one virtual experienceas the at least one artificial sensory experience. In one example,selector module 106 can select a virtual experience as the artificialsensory experience. A virtual experience may include an experience witha computer-simulated environment. Such a virtual experience may beinteractive or non-interactive. Some examples of a virtual experiencemay include an experience with a virtual world, a simulated reality, acomputer game, and/or a virtual tour, and may involve input devices suchas a keyboard, a mouse, an accelerometer-containing input device, and/ora wired glove. A virtual experience may also involve a visual and/orauditory monitoring device such as a video monitor, goggles,loudspeakers, or the like. Examples of a virtual experience includesecond life, snow world, or the like. In some instances, selector module106 may include a computer processor.

Operation 2104 illustrates selecting at least one of a virtual world, asocial networking website, an online game, an online educationalexperience, a networked game, or a single-player game. For example, asshown in FIG. 1, selector module 106 may select at least one of avirtual world, a social networking website, an online game, an onlineeducational experience, a networked game, or a single-player game. Inone instance, selector module 106 can select a virtual world. A virtualworld may include a computer-based simulated environment intended forits users to inhabit and interact via avatars, such as second life. Asocial networking website may include a website for observing and/orinteracting with one or more personal and/or professional relationshipsbetween individuals. Some examples of a social networking website mayinclude MySpace, GeoCities, Facebook, and/or LinkedIn. In one instance,selector module 106 may select Facebook as the social networking websiteand may include directions to Facebook to implement a color schemeincluding bright colors, such as yellow and light blue, for preventingthe onset of depression in a depression prone viewer. An online game mayinclude a game played over a network, such as hardwired terminals, awireless network, a modem network, a video console, and/or the internet.Some online games may include virtual worlds and/or virtual communities.Examples of online games may include World of Warcraft (WoW), FinalFantasy XI, Lineage II, Guild Wars, and/or RuneScape. An onlineeducational experience may include a tutorial, a lesson, and/or anonline class. Some examples of an online educational experience mayinclude a HTML tutorial, an online piano lesson, and/or an online degreeprogram from the University of Phoenix. A networked game may include anygame played by more than one player and may be played on a computer. Anexample of a networked game may include World of Warcraft (WoW). Asingle-player game may include any game that can be played by one playerand that may or may not be played on a computer. Examples of asingle-player game includes solitaire, puzzle games such as Tetris, Callof Duty, and Guitar Hero. In some instances, selector module 106 mayinclude a computer processor.

FIG. 22 illustrates alternative embodiments of the example operationalflow 200 of FIG. 2. FIG. 22 illustrates example embodiments whereoperation 230 may include at least one additional operation. Additionaloperations may include an operation 2202, and/or an operation 2204.

Operation 2202 illustrates selecting at least one real-world sensorystimulus as the at least one artificial sensory experience. For example,as shown in FIG. 1, selector module 106 may select at least onereal-world sensory stimulus as the at least one artificial sensoryexperience. In one instance, selector module 106 can select a real-worldsensory stimulus including an aroma as an artificial sensory experience.Some examples of a real-world sensory stimulus may include aromas and/orsmells, sounds, sights, touch, pressure, temperature and/or heat, and/orvibration. In some instances, selector module 106 may include a computerprocessor. Further, operation 2204 illustrates selecting at least one ofa smell, a taste, a sound, a physical contact, or a sight as the atleast one real-world sensory stimulus. For example, as shown in FIG. 1,selector module 106 may select at least one of a smell, a taste, asound, a physical contact, or a sight as the at least one real-worldsensory stimulus. In one example, selector module 106 selects a smelland a taste as a real-world sensory stimulus. A smell may include anyproperty detected by the nose and/or olfactory system. A taste mayinclude any flavor and/or property detected by the tongue and/or tastebuds. A sound may include any sound wave that may be detected by theeardrum. A physical contact may include anything related to touch, feel,and/or detection by the skin and/or body, and/or physical activityincluding exercise. In one instance, selector module 106 may select aphysical contact including physical exercise associated withparticipating in playing a tennis game on a Nintendo Wii video gameconsole, for example. A sight may include any image, and/or lightdetected by the eyes. In some instances, selector module 106 may includea computer processor.

FIG. 23 illustrates alternative embodiments of the example operationalflow 200 of FIG. 2. FIG. 23 illustrates example embodiments whereoperation 230 may include at least one additional operation. Additionaloperations may include an operation 2302, an operation 2304, and/or anoperation 2306.

Operation 2302 illustrates selecting the at least one artificial sensoryexperience at least partially based on at least one of a behavior, asymptom, or a diagnosis. For example, as shown in FIG. 1, selectormodule 106, may select the at least one artificial sensory experience atleast partially based on at least one of a behavior, a symptom, or adiagnosis. In one example, selector module 106 can select an artificialsensory experience based on behavior entered by a user 118 via a userinterface 116. A behavior may include the manner in which a personand/or thing acts and/or reacts. A symptom may include a manifestation,sign, and/or an indication of the presence of a disease and/or someother disorder and/or abnormality. A diagnosis may include identifying adisease and/or condition by its signs and/or symptoms. For example,selector module 106 and/or system 100 may select an immersive virtualreality experience as the at least one artificial sensory experience atleast partially based on a pain symptom and/or a third-degree burndiagnosis. In some instances, selector module 106 may include a computerprocessor.

Operation 2304 illustrates selecting the at least one artificial sensoryexperience at least partially based on at least one demographiccharacteristic of the at least one individual. For example, as shown inFIG. 1, selector module 106 may select the at least one artificialsensory experience at least partially based on at least one demographiccharacteristic of the at least one individual. In one example, selectormodule 106 can select an artificial sensory experience based on ademographic characteristic the at least one individual. A demographiccharacteristic may include a socioeconomic, age, gender, and/or othersimilar factor defining a certain population. For example, selectormodule 106 and/or system 100 may select a virtual reality experiencesuch as a Sesame Street or Disney-themed experience as the at least oneartificial sensory experience at least partially based on an indicationthat the individual is aged 6-10 years old. In some instances, selectormodule 106 may include a computer processor.

Further, operation 2306 illustrates selecting the at least oneartificial sensory experience at least partially based on at least oneof geographic location, family status, age, gender, weight, ethnicity,body mass index, household size, or income of the at least oneindividual. For example, as shown in FIG. 1, selector module 106 mayselect the at least one artificial sensory experience at least partiallybased on at least one of geographic location, family status, age,gender, weight, ethnicity, body mass index, household size, or income ofthe at least one individual. In one example, selector module 106 canselect the artificial sensory experience based on an age and a weightassociated with the at least one individual. A geographic location mayinclude a location where an individual currently resides, has resided inthe past, and/or has visited. A family status may include maritalstatus, status and/or presence of children, and/or the status and/orhealth of extended family. In some instances, selector module 106 mayinclude a computer processor.

FIG. 24 illustrates alternative embodiments of the example operationalflow 200 of FIG. 2. FIG. 24 illustrates example embodiments whereoperation 230 may include at least one additional operation. Additionaloperations may include an operation 2402, and/or an operation 2404.

Operation 2402 illustrates selecting the at least one artificial sensoryexperience at least partially based on at least one of a medicationhistory or an artificial sensory experience history of the at least oneindividual. For example, as shown in FIG. 1, selector module 106 mayselect the at least one artificial sensory experience at least partiallybased on at least one of a medication history or an artificial sensoryexperience history of the at least one individual. In one instance,selector module 106 can select an artificial sensory experience based onan artificial sensory experience history of the at least one individual.An artificial sensory experience history may include any record of atleast one administered artificial sensory experience history. Forexample, system 100 and/or selector module 106 may select a modifiedfacebook webpage having a cheerful color scheme at least partly based ona facebook usage history for an individual with signs of depression. Insome instances, selector module 106 may include a computer processor.

Operation 2404 illustrates selecting a preferred artificial sensoryexperience and at least one alternative artificial sensory experience.For example, as shown in FIG. 1, selector module 106 may select apreferred artificial sensory experience and at least one alternativeartificial sensory experience. In one example, selector module 106 canselect a preferred artificial sensory experience and at least onealternative artificial sensory experience. A preferred artificialsensory experience may include a more desirable artificial sensoryexperience due to a lack of and/or a reduced level of side effects,reduced impact upon the individual, and/or increased compatibility withanother medications and/or treatment. An alternative artificial sensoryexperience may include any artificial sensory experience in addition tothe preferred artificial sensory experience and may be less desirablethan the preferred artificial sensory experience due to side effectsand/or increased impact upon the individual. In some instances, selectormodule 106 may include a computer processor.

FIG. 25 illustrates alternative embodiments of the example operationalflow 200 of FIG. 2. FIG. 25 illustrates example embodiments whereoperation 230 may include at least one additional operation. Additionaloperations may include an operation 2502, an operation 2504, and/or anoperation 2506.

Operation 2502 illustrates selecting at least one artificial sensoryexperience and at least one prescription medication at least partiallybased on a treatment algorithm. For example, as shown in FIG. 1,selector module 106 may select at least one artificial sensoryexperience and at least one prescription medication at least partiallybased on a treatment algorithm. In one instance, selector module 106 canselect an artificial sensory experience and a prescription medicationbased on a computer software treatment algorithm. A treatment algorithmmay include any computation, formula, statistical survey, and/or took-uptable for determining and/or selecting a suitable artificial sensoryexperience and prescription medication combination. Some examples mayinclude a computer software algorithm, a calculator, a flowchart, and/ora decision tree. For example, system 100 and/or selector module 106 may,based on an accepted pain symptom of an individual, access a lookupchart that matches the pain symptom with a pain medication, such asnaproxen, and a virtual experience, such as World of Warcraft. Such acombination therapy may be particularly effective in ameliorating thepain symptom in the individual. In some instances, selector module 106may include a computer processor.

Further, operation 2504 illustrates selecting at least one prescriptionmedication at least partially based on at least one of a drug allergyassociated with the at least one individual or a drug interactionassociated with the at least one prescription medication. For example,as shown in FIG. 1, selector module 106 may select at least oneprescription medication at least partially based on at least one of adrug allergy associated with the at least one individual or a druginteraction associated with the at least one prescription medication. Inone example, selector module 106 can select a prescription medicationbased on a drug allergy associated with the at least one individual. Adrug allergy may include any allergy to a drug and/or drug intolerance.Some examples of a drug allergy may include penicillin allergies,codeine allergies, and/or allergies to a dye in a drug. A druginteraction may include an undesirable and/or unwanted reaction betweentwo or more drugs and/or medications. For example, the system 100 and/orselector module 106 can select a prescription medication other thanthose that might cause a side effect in an individual, perhaps becauseof a known predisposition to the side effect (e.g., an allergy) orbecause of a known drug-drug interaction relevant to the individualbased on the individual's medication regimen. In this way, risk of sideeffects can be lessened. In some instances, selector module 106 mayinclude a computer processor.

Operation 2506 illustrates selecting at least one opioid analgesic andat least one virtual world experience to address at least one painattribute of at least one individual. For example, as shown in FIG. 1,selector module 106 may select from a prescription medication databaseat least one opioid analgesic and at least one virtual world experienceto address at least one pain attribute of at least one individual. Inone example, selector module 106 can select an opioid analgesicincluding morphine and a virtual world experience including an onlinegame to address a pain attribute of at least one individual named MaryAndersen. In some instances, selector module 106 may include a computerprocessor.

FIG. 26 illustrates alternative embodiments of the example operationalflow 200 of FIG. 2. FIG. 26 illustrates example embodiments whereoperation 240 may include at least one additional operation. Additionaloperations may include an operation 2602, an operation 2604, and/or anoperation 2606.

Operation 2602 illustrates presenting an indication of a preferredcombination including at least one prescription medication and at leastone artificial sensory experience and at least one alternativecombination including at least one alternative prescription medicationand at least one alternative artificial sensory experience. For example,as shown in FIG. 1, presenter module 108 may present an indication of apreferred combination including at least one prescription medication andat least one artificial sensory experience and at least one alternativecombination including at least one alternative prescription medicationand at least one alternative artificial sensory experience. In oneinstance, presenter module 108 can present an indication of a preferredcombination to an individual 134 including a prescription medication andan artificial sensory experience along with an alternative combinationincluding an alternative prescription medication and an alternativeartificial sensory experience. Individual 134 may include a singleindividual, multiple individuals, and/or an entity. A preferredcombination may include a more desirable combination due to a lack ofand/or a reduced number of and/or level of side effects, reduced impactupon the administered individual, and/or increased compatibility withanother medications and/or treatment. An alternative combination mayinclude any combination in addition to the preferred combination and maybe ostensibly less desirable than the preferred artificial sensoryexperience because of a potential side effect and/or impact upon theadministered individual. Presentation of alternative combinations mayprovide benefits to the individual in terms of accessibility,affordability, and/or personal preference of medication and/orartificial sensory experience. In some instances, presenter module 108may include a computer processor.

Operation 2604 illustrates presenting an indication of the at least oneprescription medication and the at least one artificial sensoryexperience to at least one output device. For example, as shown in FIG.1, presenter module 108 may present an indication of the at least oneprescription medication and the at least one artificial sensoryexperience to at least one output device. In one example, presentermodule 108 can present an indication of a prescription medication and anartificial sensory experience to an output device 130 including aprinter at a health clinic. An output device may include any hardwaredevice configured for receiving computer output. Some examples of anoutput device may include a printer, a monitor, a mobile phone, aspeaker, and/or a visual display unit. The output device may be used byindividual 134. In some instances, presenter module 108 may include acomputer processor.

Further, operation 2606 illustrates presenting an indication of at leastone of the at least one prescription medication or the at least oneartificial sensory experience to at least one user interface. Forexample, as shown in FIG. 1, presenter module 108 may present anindication of at least one of the at least one prescription medicationor the at least one artificial sensory experience to at least one userinterface. In one instance, presenter module 108 can present anindication of a prescription medication and an artificial sensoryexperience to a user interface. A user interface may include means bywhich an individual may interact with a system. Some examples of a userinterface may include a touchscreen, a graphical user interface, atactile interface, and/or a live user interface. In some instances,presenter module 108 may include a computer processor.

FIG. 27 illustrates alternative embodiments of the example operationalflow 200 of FIG. 2. FIG. 27 illustrates example embodiments whereoperation 240 may include at least one additional operation. Additionaloperations may include an operation 2702. Further, operation 2702illustrates presenting an indication of at least one of the at least oneprescription medication or the at least one artificial sensoryexperience to at least one mobile device. For example, as shown in FIG.1, presenter module 108 may present an indication of at least one of theat least one prescription medication or the at least one artificialsensory experience to at least one mobile device. In one instance,presenter module 108 can present an indication of a prescriptionmedication to a mobile device 132. A mobile device may include aportable computing device and may have wireless connection capability.Some examples of a mobile device may include a laptop or notebookcomputer, a personal digital assistant (PDA), an ipod, a smartphone, anEnterprise digital assistant (EDA), and/or a pager. In some instances,presenter module 108 may include a computer processor.

FIG. 28 illustrates alternative embodiments of the example operationalflow 200 of FIG. 2. FIG. 28 illustrates example embodiments whereoperation 240 may include at least one additional operation. Additionaloperations may include an operation 2802, and/or an operation 2804.

Operation 2802 illustrates presenting to a health care provider anindication of at least one of the at least one prescription medicationor the at least one artificial sensory experience at least partly basedon the selecting at least one prescription medication and at least oneartificial sensory experience to address the at least one attribute ofat least one individual. For example, as shown in FIG. 1, presentermodule 108 may present to a health care provider an indication of atleast one of the at least one prescription medication or the at leastone artificial sensory experience at least partly based on the selectingat least one prescription medication and at least one artificial sensoryexperience to address an attribute of an individual. In one example,presenter module 108 can present to a health care provider 128 anindication of a prescription medication based on the selecting at leastone prescription medication and at least one artificial sensoryexperience to address the at least one attribute 120 of at least oneindividual. A health care provider may include a pharmacy, apharmaceutical company, a medical device company, a researchinstitution, a computer software and/or computer hardware company, awebsite, a nurse and/or a physician. In some instances, presenter module108 may include a computer processor.

Operation 2804 illustrates presenting an indication of the at least oneprescription medication or the at least one artificial sensoryexperience at a staggered time. For example, as shown in FIG. 1,presenter module 108 may present an indication of at least one of the atleast one prescription medication or the at least one artificial sensoryexperience at a staggered time. In one example, presenter module 108 canpresent an indication of a series of prescription medications and anartificial sensory experience at staggered times. A staggered time mayinclude presenting an indication of the at least one drug and/orartificial sensory experience at overlapping times and/or at differenttimes, including alternating times. For example, at least one drug andan artificial sensory experience may be administered at an initial timeand the same or a different drug may be administered when thefirst-administered at least one drug is at its peak effect. In anotherexample, at least one drug and an artificial sensory experience may beadministered at an initial time and the same or a different drug may beadministered when the first administered at least one drug is at itslowest effect. In another example, an artificial sensory experience maybe administered at an initial time and at least one prescriptionmedication at a later time. The at least one artificial sensoryexperience and/or the at least one prescription medication may beadministered at any number of times either concurrently, partiallyconcurrently, or not concurrently. In some instances, presenter module108 may include a computer processor.

FIG. 29 illustrates an operational flow 2900 representing exampleoperations related to querying at least one database at least partlybased on at least one attribute of an individual, selecting from the atleast one database at least one prescription medication to address theat least one attribute of at least one individual, and/or implementingat least one artificial sensory experience to address the at least oneattribute of at least one individual in response to a selected at leastone prescription medication. In FIG. 29, discussion and explanation maybe provided with respect to the above-described examples of FIG. 1,and/or with respect to other examples and contexts. However, it shouldbe understood that the operational flows may be executed in a number ofother environments and contexts, and/or in modified versions of FIG. 1.Also, although the various operational flows are presented in thesequence(s) illustrated, it should be understood that the variousoperations may be performed in other orders than those which areillustrated, or may be performed concurrently.

After a start operation, the operational flow 2900 moves to an operation2910. Operation 2910 depicts querying at least one database at leastpartly based on at least one attribute of an individual. For example, asshown in FIG. 1, querier module 104 may search at least one database atleast partly based on at least one attribute of an individual. In oneinstance, querier module 104 may search medication database 124 andartificial sensory experience database 126 based on an attribute 120including an indication of hypertension associated with an individualnamed John Smith. In some instances, querier module 104 may include acomputer processor.

Then, operation 2920 depicts selecting from the at least one database atleast one prescription medication to address the at least one attributeof at least one individual. For example, as shown in FIG. 1, selectormodule 106 may select from the at least one database at least oneprescription medication to address the at least one attribute of atleast one individual. In one example and continuing with the previousexample, selector module 106 may select from medication database 124 andartificial sensory experience database 126 a prescription medicine foraddressing the attribute 120 including an indication of hypertensionassociated with an individual named John Smith. In some instances,selector module 106 may include a computer processor.

Then, operation 2930 depicts implementing at least one artificialsensory experience to address the at least one attribute of at least oneindividual in response to a selected at least one prescriptionmedication. For example, as shown in FIG. 1, implementer module 138 mayimplement at least one artificial sensory experience to address the atleast one attribute of at least one individual in response to a selectedat least one prescription medication. In one instance and continuingwith the previous example, implementer module 106 may implement anartificial sensory experience including a virtual world for addressingthe attribute 120 including an indication of hypertension associatedwith an individual named John Smith in response to a selectedprescription medication from a medication database 124. In someinstances, selector module 106 may include a computer processor.

FIG. 30 illustrates a partial view of an example computer programproduct 3000 that includes a computer program 3004 for executing acomputer process on a computing device. An embodiment of the examplecomputer program product 3000 is provided using a signal-bearing medium3002, and may include one or more instructions for accepting at leastone attribute of at least one individual; one or more instructions forquerying at least one database at least partly based on the at least oneattribute; one or more instructions for selecting from the at least onedatabase at least one prescription medication and at least oneartificial sensory experience to address the at least one attribute ofat least one individual; and one or more instructions for presenting anindication of the at least one prescription medication and the at leastone artificial sensory experience at least partly based on the selectingfrom the at least one database at least one prescription medication andat least one artificial sensory experience to address the at least oneattribute of at least one individual. The one or more instructions maybe, for example, computer executable and/or logic-implementedinstructions. In one implementation, the signal-bearing medium 3002 mayinclude a computer-readable medium 3006. In one implementation, thesignal bearing medium 3002 may include a recordable medium 3008. In oneimplementation, the signal bearing medium 3002 may include acommunications medium 3010.

FIG. 31 illustrates an example system 3100 in which embodiments may beimplemented. The system 3100 includes a computing system environment.The system 3100 also illustrates the user 118 using a device 3104, whichis optionally shown as being in communication with a computing device3102 by way of an optional coupling 3106. The optional coupling 3106 mayrepresent a local, wide-area, or peer-to-peer network, or may representa bus that is internal to a computing device (e.g., in exampleembodiments in which the computing device 3102 is contained in whole orin part within the device 3104). A storage medium 3108 may be anycomputer storage media.

The computing device 3102 includes computer-executable instructions 3110that when executed on the computing device 3102 cause the computingdevice 3102 to accept at least one attribute of at least one individual;query at least one database at least partly based on the at least oneattribute; select from the at least one database at least oneprescription medication and at least one artificial sensory experienceto address the at least one attribute of at least one individual; andpresent an indication of the at least one prescription medication andthe at least one artificial sensory experience at least partly based onthe selecting from the at least one database at least one prescriptionmedication and at least one artificial sensory experience to address theat least one attribute of at least one individual. As referenced aboveand as shown in FIG. 31, in some examples, the computing device 3102 mayoptionally be contained in whole or in part within the device 3104.

In FIG. 31, then, the system 3100 includes at least one computing device(e.g., 3102 and/or 3104). The computer-executable instructions 3110 maybe executed on one or more of the at least one computing device. Forexample, the computing device 3102 may implement the computer-executableinstructions 3110 and output a result to (and/or receive data from) thecomputing device 3104. Since the computing device 3102 may be wholly orpartially contained within the computing device 3104, the device 3104also may be said to execute some or all of the computer-executableinstructions 3110, in order to be caused to perform or implement, forexample, various ones of the techniques described herein, or othertechniques.

The device 3104 may include, for example, a portable computing device,workstation, or desktop computing device. In another example embodiment,the computing device 3102 is operable to communicate with the device3104 associated with the user 118 to receive information about the inputfrom the user 118 for performing data access and data processing andpresenting an output of the user-health test function at least partlybased on the user data.

Although a user 118 is shown/described herein as a single illustratedfigure, those skilled in the art will appreciate that a user 118 may berepresentative of a human user, a robotic user (e.g., computationalentity), and/or substantially any combination thereof (e.g., a user maybe assisted by one or more robotic agents). In addition, a user 118, asset forth herein, although shown as a single entity may in fact becomposed of two or more entities. Those skilled in the art willappreciate that, in general, the same may be said of “sender” and/orother entity-oriented terms as such terms are used herein.

FIG. 32 illustrates a system 3200 for detecting at least one indicationof bioactive agent use by an individual and altering an artificialsensory experience to modify at least one effect of the bioactive agent.The system 3200 may include acceptor module 102, querier module 104,selector module 106, presenter module 108, implementer module 138,detector module 140, and/or alterer module 148. Acceptor module 102 mayreceive attribute 120 from network storage 110, memory device 112,database entry 114, and/or user interface 116. User interface 116 mayreceive information from user 118. User 118 may include health careprovider 136. Querier module 104 may search database 122. Database 122may include medication database 124 and/or artificial sensory experiencedatabase 126. Presenter module 108 may present to health care provider128, output device 130, and/or individual 134. Output device 130 mayinclude mobile device 132. Detector module 140 may include analyzermodule 142 and/or comparer module 146. Analyzer module 142 may includedetector module 144. Alterer module 148 may include restrictor module150, granter module 152, adder module 154, and/or deleter module 156.System 3200 generally represents instrumentality for detecting at leastone indication of bioactive agent use by an individual and altering anartificial sensory experience to modify at least one effect of thebioactive agent. The operations of detecting at least one indication ofbioactive agent use by an individual and altering an artificial sensoryexperience to modify at least one effect of the bioactive agent may beaccomplished electronically, such as with a set of interconnectedelectrical components, an integrated circuit, and/or a computerprocessor.

FIG. 33 illustrates an operational flow 3300 representing exampleoperations related to detecting at least one indication of bioactiveagent use by an individual and altering an artificial sensory experienceto modify at least one effect of the bioactive agent. In FIG. 33 and infollowing figures that include various examples of operational flows,discussion and explanation may be provided with respect to theabove-described examples of FIG. 32, and/or with respect to otherexamples and contexts. However, it should be understood that theoperational flows may be executed in a number of other environments andcontexts, and/or in modified versions of FIG. 32. Also, although thevarious operational flows are presented in the sequence(s) illustrated,it should be understood that the various operations may be performed inother orders than those which are illustrated, or may be performedconcurrently.

After a start operation, the operational flow 3300 moves to an operation3310. Operation 3310 depicts detecting at least one indication ofbioactive agent use by an individual. For example, as shown in FIG. 32,detector module 140 may detect at least one indication of bioactiveagent use by an individual. In one instance, detector module 140 maydetect an indication of bioactive agent use including opioid use by ananonymous individual. Detecting may include discovering and/orascertaining an existence of an indication of bioactive agent use. Anindication of bioactive agent use may include a showing of bioactiveagent use, such as the results of a chemical test and/or input from auser 118 and/or health care provider 136. In some cases, detectedbehavior may provide the indication of bioactive agent use. Detectedbehavior may include user actions and or other physical behavior able tobe sensed, such as cognitive activity, voluntary body movement, speech,indicia of attention and/or alertness, blood pressure, vital signs,and/or heart rate, or the like. Detected behavior may also include adetected absence of a behavior (e.g. detection of the absence ofanxiety, for example by detecting markers such as normal blood pressure,normal pulse, normal perspiration levels, or the like).

Additionally, behavior may be detected and/or monitored remotely and/orindirectly, for example via a user's actions in a virtual environment.For example, detected body movement may whether a user diagnosed withclinical depression is exhibiting signs of depression (See “Something inthe way he moves,” The Economist, 27 Sep. 2007), which is incorporatedherein by reference. Such body movements may be detected using a camera,an accelerometer, and/or a sensor, or the like. Behavior may also bedetected by monitoring a user's behavior in a virtual environment, suchas a computer game. For example, completion of tasks in a computer gameenvironment may be diagnostic for exhibition of symptoms of depression(See “Video game may help detect depression,” New Scientist, Issue 2594,10 Mar. 2007, page 18).

In another embodiment, detector module 140 may remotely detect adecreased heart rate in an anxious person subsequent to theadministration of and during the bioavailability of an anti-anxietymedication in the person. An example including remote detection andmonitoring of vital signs may be found in Money, et al., U.S. Pat. No.5,919,141, which is incorporated herein by reference. A bioactive agentmay include an agent that may have a biochemical and/or biologicaleffect on any part of the human body. One example of a bioactive agentmay include a pharmaceutical agent, such as codeine and/oracetaminophen. Such bioactive agents have one or more desiredtherapeutic effects. Another example of a bioactive agent may include anillegal and/or addictive substance, such as methamphetamine and/oralcohol. Additionally, an effect of a bioactive agent may include aneffect associated with the bioactive agent, such as a side effect, anadverse drug reaction, and/or an unintended therapeutic effect. In someinstances, detector module 140 may include a computer processor.

Then, operation 3320 depicts altering an artificial sensory experienceto modify at least one effect of the bioactive agent. For example, asshown in FIG. 32, alterer module 148 may alter an artificial sensoryexperience to modify at least one effect of the bioactive agent. In oneinstance, alterer module 148 may alter an artificial sensory experienceincluding a virtual world to modify an effect of the bioactive agent.Some examples of an artificial sensory experience may include a virtualexperience, such as an online game (e.g., World of Warcraft) or a socialnetworking site (e.g., Facebook), and/or a real-world sensory stimulus,such as a specific aroma and/or a sight (e.g., a specific lightingscheme). Examples of modifying an artificial sensory experience mayinclude changing a computer game (e.g., adding a new character) and/orchanging a computer display background. One example of an artificialsensory experience may include a game utilizing a neuroheadset havingsensors for detecting mental states based on, for example, electricalsignals, optical signals, and/or blood flow in the brain. See, forexample, headsets manufactured by Emotiv Systems, Inc. In someinstances, modifier module 140 may include a computer processor.

FIG. 34 illustrates alternative embodiments of the example operationalflow 3300 of FIG. 33. FIG. 34 illustrates example embodiments where theoperation 3310 may include at least one additional operation. Additionaloperations may include an operation 3402, an operation 3404, and/or anoperation 3406.

Operation 3402 illustrates analyzing at least one of sweat, blood,breath, heart rate, brain activity, respiration, or voice quality todetect the at least one indication of bioactive agent use by theindividual. For example, as shown in FIG. 32, analyzer module 142 mayanalyze at least one of sweat, blood, breath, heart rate, brainactivity, respiration, or voice quality to detect the at least oneindication of bioactive agent use by the individual. In someembodiments, any bodily solid, fluid and/or gas may be analyzed. In oneinstance, analyzer module 142 may analyze blood and breath to detect anindication of alcohol and/or illegal drug use by an anonymousindividual. Some examples of sweat analysis may include collecting asweat sample and testing the sweat sample, such as by determiningchloride concentration and/or measuring conductivity. One example ofsweat collection and analysis may be described in Webster et al., U.S.Pat. No. 6,198,953, which is incorporated herein by reference. Analyzingblood may include measuring blood components and/or measuring substancesfound in blood. Some blood tests may include complete blood cell count,live blood analysis, and/or blood typing. Breath analysis may includetesting components of exhaled air, such as a breathalyzer test forestimating blood alcohol content. Heart rate analysis may includemeasuring heart rate, such as using a pulse, an electrocardiograph,and/or stethoscope, and performing an analysis, such as using statistics(analysis of heart rate variation) or a graph (electrocardiograph). Oneexample of analyzing brain activity may include usingelectroencephalography and observing brain wave patterns. Respirationanalysis may include analysis of breathing and/or the inhalation andexhalation of air. One example of respiration analysis may includeutilizing a capnograph, such as described in Carlebach et al, U.S. Pat.No. 6,997,880, which is incorporated herein by reference. Voice qualityanalysis may include measuring voice behavior, such as rate of speech,voice volume, voice tone, and/or speech disorders, such as stuttering.In some instances, analyzer module 142 may include a computer processor.Further, operation 3404 illustrates analyzing brain activity using atleast one of near infra-red imaging, EEG, magnetoencephalography,functional magnetic resonance imaging, or computer-aided tomography. Forexample, as shown in FIG. 32, analyzer module 142 may analyze brainactivity using at least one of near infra-red imaging, EEG,magnetoencephalography, functional magnetic resonance imaging, orcomputer-aided tomography. In one instance, analyzer module 142 mayanalyze brain activity using magnetoencephalography. Near infra-redimaging may include thermography and/or determining the temperature ofan object by detecting radiation in the infrared range of theelectromagnetic spectrum. EEG (electroencephalography) may includemeasurement of electrical activity produced by the brain recorded fromelectrodes placed on the scalp. Magnetoencephalography may include animaging technique used to measure magnetic fields produced by electricalactivity in the brain using extremely sensitive devices, such assuperconducting quantum interference devices (SQUIDs). Functionalmagnetic resonance imaging may include measuring the haemodynamicresponse related to neural activity in the brain or spinal cord. Opticalimaging methods known in the art may also be used. Computer-aidedtomography may include gathering projection data from multipledirections and feeding the data into a tomographic reconstructionsoftware algorithm processed by a computer. Some examples ofcomputer-aided tomography may include a CT scan, single photon emissioncomputed tomography (SPECT), magnetic resonance imaging (MRI), and/ormedical sonography (ultrasonography). In some instances, analyzer module142 may include a computer processor.

Further, operation 3406 illustrates detecting at least one of ananti-depressant, an anxiolytic medication, a pain medication, a behaviormodifying medication, a weight modifying drug, a neurodegenerativedisorder medication, or a vascular disease medication as the at leastone medication. For example, as shown in FIG. 32, detector module 144may detect at least one of an anti-depressant, an anxiolytic medication,a pain medication, a behavior modifying medication, a weight modifyingdrug, a neurodegenerative disorder medication, or a vascular diseasemedication as the at least one medication. In one instance, detectormodule 144 may detect a pain medication as the at least one medication.An anti-depressant may include a psychiatric medication or othersubstance, such as a nutrient or herb, used for alleviating depressionor dysthymia. Some examples of an anti-depressant may include fluoxetineand/or sertraline. An anxiolytic medication may include a substance usedfor the treatment of anxiety, such as a benzodiazepine and/or abarbiturate. A pain medication may include any substance and/or drugused to relieve pain. Some examples of an analgesic may includenarcotics such as morphine or oxycodone, non-narcotics, an NSAID such asaspirin or naproxen or ibuprofen, and/or acetaminophen. A behaviormodifying medication may include a substance used for preventing,changing, and/or reducing behavior, such as that associated withattention-deficit disorder (ADD), attention-deficit hyperactivitydisorder (ADHD), attachment disorders, associative disorders,oppositional defiant disorder, aggression, autistic spectrum disorders,and/or other abnormal behavior. Some examples of a behavior modifyingmedication may include methylphenidate, dextroamphetamine, and/or mixedamphetamine salts. A weight modifying drug may include a drug and/orsupplement used for increasing, decreasing, and/or changing appetiteand/or body weight, blocking fat absorption, and/or decreasing stomachvolume. Some examples of a weight modifying drug may include DHEA,pregnenolone, orlistat, sibutramine, and/or melatonin. Aneurodegenerative disorder medication may include medication used forthe prevention and/or management of a neurodegenerative disorder, suchas Alzheimer's disease, Parkinson's disease, Pick's disease, MultipleSystem Atrophy, and/or Huntington's disease. Some examples of aneurodegenerative disorder medication may include memantine, donepezil,galantamine, and/or rivastigmine. A vascular disease medication mayinclude medication used for preventing and/or treating diseases that mayinvolve the heart or blood vessels including arteries and veins. Someexamples of vascular disease may include thrombosis, myocardialinfarction, stroke, atherosclerosis, aneurysm, or the like. Someexamples of vascular disease medication may include aspirin,clopidogrel, and/or ticlopidine. In some instances, detector module 144may include a computer processor.

FIG. 35 illustrates alternative embodiments of the example operationalflow 3300 of FIG. 33. FIG. 35 illustrates example embodiments where theoperation 3310 may include at least one additional operation. Additionaloperations may include an operation 3502, an operation 3504, anoperation 3506, and/or an operation 3508.

Operation 3502 illustrates detecting a concentration of the bioactiveagent in the individual. For example, as shown in FIG. 32, detectormodule 140 may detect a concentration of the bioactive agent in theindividual. In one example, detector module 140 may detect aconcentration of 28 mg/L of ibuprofen in, for example, the blood of anindividual named Judy Edwards. A concentration may include a measurementof the quantity of a first substance in a given volume and/or a secondsubstance. Some examples of concentration may include mass versus volume(mg/L), “parts per” notation (parts per million), and/or molarity(mol/L). In some instances, detector module 140 may include a computerprocessor.

Operation 3504 illustrates comparing a measured value of the bioactiveagent in the individual to a stored baseline value of the bioactiveagent for the individual to identify a differential indicative ofbioactive agent use. For example, as shown in FIG. 32, comparer module146 may compare a measured value of the bioactive agent in theindividual to a stored baseline value of the bioactive agent for theindividual to identify a differential indicative of bioactive agent use.In one instance, comparer module 146 may compare a measured value ofhydrocodone in a specific individual to a stored baseline value ofhydrocodone for the specific individual for identifying a differentialindicative of use of hydrocodone by the specific individual. A baselinevalue may include a guideline and/or a standard level of a measuredvalue to compare a separate measured value with. A baseline value may bestored in computer data storage, such as a hard disk, or in another datastorage device, such as a paper file and/or a digital video disk. Adifferential indicative of bioactive agent use may include a positivedifference or a negative difference. In some instances, comparer module146 may include a computer processor.

Operation 3506 illustrates detecting substance use by the individual.For example, as shown in FIG. 32, detector module 140 may detectsubstance use by the individual. In one example, detector module 140 maydetect cocaine use by the individual. Substance abuse may include anoverindulgence in and dependence on a drug, substance, and/or otherchemical leading to effects that may be detrimental to an individual'sphysical and/or mental health, and/or the welfare of others. Substanceabuse may be detected by identifying an increase in a drug and/or othersubstance, such as analyzing a blood, sweat, and/or urine test. In somecases, behavior may provide evidence of substance use and/or abuse. Insome instances, detector module 140 may include a computer processor.Further, operation 3508 illustrates detecting at least one of alcoholuse, psychoactive drug use, tranquilizer use, methamphetamine use, ornarcotic use. For example, as shown in FIG. 32, detector module 140 maydetect at least one of alcohol use, psychoactive drug use, tranquilizeruse, methamphetamine use, or narcotic use. In one example, detectormodule 140 may detect alcohol use and methamphetamine use. Alcohol mayinclude a drink containing ethanol, such as beer or wine. A psychoactivedrug may include a chemical substance that acts primarily upon thecentral nervous system where it alters brain function, resulting intemporary changes in perception, mood, consciousness and behaviour. Someexamples of a psychoactive drug may include codeine, cannabis,fluoxetine, and/or lithium carbonate. A tranquilizer may include asubstance that depresses the central nervous system (CNS) and may resultin calmness, relaxation, reduction of anxiety, sleepiness, and slowedbreathing, as well as slurred speech, staggering gait, poor judgment,and stow, uncertain reflexes. Some examples of a tranquilizer mayinclude alprazolam and/or diazepam. Methamphetamine is a drug that mayact as a psychostimulant and/or sympathomimetic. A narcotic may includean agent that benumbs or deadens and may cause loss of feeling and/orparalysis. Some examples of a narcotic may include an opioid, such asmorphine and/or fentanyl. In some instances, detector module 140 mayinclude a computer processor.

FIG. 36 illustrates alternative embodiments of the example operationalflow 3300 of FIG. 33. FIG. 36 illustrates example embodiments where theoperation 3310 may include at least one additional operation. Additionaloperations may include an operation 3602, an operation 3604, and/or anoperation 3606.

Operation 3602 illustrates detecting a nutraceutical used by theindividual. For example, as shown in FIG. 32, detector module 140 maydetect a nutraceutical used by the individual. In one example, detectormodule 140 may detect resveratrol used by the individual. Anutraceutical may refer to a food extract claimed to have a medicinaleffect on human health. Some examples of a nutraceutical may includeflavonoid antioxidants, resveratrol, alpha-linolenic acid from flaxseeds, beta-carotene from marigold petals, anthocyanins from berries,ginseng, and/or garlic oil. In some instances, detector module 140 mayinclude a computer processor. Further, operation 3604 illustratesdetecting at least one of a memory supplement, an anti-oxidant, a cancerpreventative, or a mood-changing agent. For example, as shown in FIG.32, detector module 140 may detect at least one of a memory supplement,an anti-oxidant, a cancer preventative, or a mood-changing agent. In oneinstance, detector module 140 may accept an identification of an herbalmemory supplement including ginkgo biloba. A memory supplement mayinclude a substance obtained from an animal and/or a plant source formaintaining and/or improving memory, such as salvia lavandulaefoliaand/or ginkgo biloba. An anti-oxidant may include a substance capable ofslowing or preventing the oxidation of other molecules and is purportedto neutralize hazardous free-radicals within the body. Some examples ofan antioxidant may include ascorbic acid, glutathione, melatonin, and/ortocopherol. A cancer preventative may include a drug, a treatment,and/or substance utilized for preventing the occurrence of and/or theprogression of cancer. Some examples of a cancer preventative mayinclude acupuncture, all-trans retinoic acid, mistletoe derivatives,and/or lycopene. A mood-changing agent may include a psychiatricmedication used to treat mood disorders characterized by intense andsustained mood shifts. Some examples of a mood-changing agent mayinclude lithium carbonate and/or lamotrigine. In some instances,detector module 140 may include a computer processor.

Operation 3606 illustrates detecting at least one indication ofbioactive agent use by at least one of a computer game participant, asocial networking website participant, a virtual world participant, anonline student, an online medical information user, or an on-lineshopper. For example, as shown in FIG. 32, detector module 140 maydetect at least one indication of bioactive agent use by at least one ofa computer game participant, a social networking website participant, avirtual world participant, an online student, an online medicalinformation website user, or an on-line shopper. In one instance,detector module 140 may detect an indication of bioactive agent use by avirtual world participant. In another instance, detector module 140 maydetect an indication of bioactive agent use by an online studentenrolled in an online college course through a community college. Inanother instance, detector module 140 may detect an indication ofbioactive agent use by an online medical information website user usinga secure connection. Online communications may include private and/orconfidential communications using a secure method, such as a secure webbrowser and/or a secure internet connection, for ensuring the privacy ofa user and/or participant. A computer game may include an online game,an online educational experience, a networked game, and/or asingle-player game. Some examples of computer games may include World ofWarcraft (WoW), solitiare, and/or RuneScape. A social networking websitemay include a website for observing and/or interacting with one or morepersonal and/or professional relationships between individuals. Someexamples of a social networking website may include MySpace, GeoCities,Facebook, and/or LinkedIn. A virtual world may include a computer-basedsimulated environment intended for its users to inhabit and interact viaavatars, such as Second Life. An online student may be enrolled inand/or learn from an online educational experience such as a tutorial, alesson, and/or an online class. Some examples of an online educationalexperience may include a HTML tutorial, an online piano lesson, and/oran online degree program from the University of Phoenix. Online medicalinformation may include a website and/or a database, such ashttp://www.ncbi.nlm.gov/pubmed/, MEDLINE, MEDLARS, and/orhttp://www.webmd.com/. An online shopper may shop at an internetmarketplace, such as eBay.com, Amazon.com, and/or Froogle.com. In someinstances, detector module 140 may include a computer processor.

FIG. 37 illustrates alternative embodiments of the example operationalflow 3300 of FIG. 33. FIG. 37 illustrates example embodiments where theoperation 3320 may include at least one additional operation. Additionaloperations may include an operation 3702, an operation 3704, and/or anoperation 3706.

Operation 3702 illustrates altering access to at least a portion of theartificial sensory experience to modify at least one effect of thebioactive agent. For example, as shown in FIG. 32, alterer module 148may alter access to at least a portion of the artificial sensoryexperience to modify at least one effect of the bioactive agent. In oneinstance, alterer module 148 may alter access to a portion of anartificial sensory experience including a photo gallery portion of asocial network website to modify at least one effect of the bioactiveagent, for example, an antidepressant. Such altered access may functiontherapeutically to prevent access of an individual to potentiallydepressing, stressful, or otherwise triggering sensory experiences,and/or the modified access may involve presentation of a sensoryexperience that affirmatively improves a condition (e.g., bright sunnyimages for a clinically depressed individual). In some instances,alterer module 148 may include a computer processor.

Further, operation 3704 illustrates restricting access to at least aportion of the artificial sensory experience. For example, as shown inFIG. 32, restrictor module 150 may restrict access to at least a portionof the artificial sensory experience. In one instance, restrictor module150 may restrict access to a portion of an artificial sensory experienceincluding a virtual world designed to overcome a flying phobia, whereaccess to a portion of a simulated flying experience is restrictedincluding a jet take-off portion. In some instances, restrictor module150 may include a computer processor. Further, operation 3706illustrates granting access to at least a portion of the artificialsensory experience. For example, as shown in FIG. 32, granter module 152may grant access to at least a portion of the artificial sensoryexperience. In one instance and continuing with the above example,granter module 152 may grant access to at least a portion of a virtualworld designed to overcome a flying phobia, where access to a portion ofa simulated flying experience is granted including a jet landingportion. Such a simulation with gradually increasing contact with theobject of the fear may serve to provide conditioning for the individualto eventually overcome the phobia. In some instances, granter module 152may include a computer processor.

FIG. 38 illustrates alternative embodiments of the example operationalflow 3300 of FIG. 33. FIG. 38 illustrates example embodiments where theoperation 3320 may include at least one additional operation. Additionaloperations may include an operation 3802, an operation 3804, and/or anoperation 3806.

Operation 3802 illustrates altering a visual object in an artificialsensory experience to modify at least one effect of the bioactive agent.For example, as shown in FIG. 32, alterer module 148 may alter a visualobject in an artificial sensory experience to modify at least one effectof the bioactive agent. In one instance and continuing with the aboveexample, alterer module 148 may alter a visual object, such as addingwindow covers, in a virtual world designed to overcome a flying phobiato modify at least one effect of an anti-anxiety medication. In thisexample, the window covers may reduce anxiety experienced by theindividual in addition to anxiety reduction mediated by the anti-anxietymedication. Additional examples of a visual object may include a virtualcharacter, an action performed by the virtual character, and/orcharacter artifacts, such as weapons, clothing, and/or tools. In someinstances, alterer module 148 may include a computer processor. Further,operation 3804 illustrates altering a color scheme of an artificialsensory experience to modify at least one effect of the bioactive agent.For example, as shown in FIG. 32, alterer module 148 may alter a colorscheme of an artificial sensory experience to modify at least one effectof the bioactive agent. In one instance, alterer module 148 may alter acolor scheme by adding brighter background lights and colors in avirtual world designed to overcome depression to alter an effect of ananti-depression medication. Such a color scheme modification may help toovercome depression, seasonal affective disorder, and/or other disordersbecause it has been purported that color and/or light may affectnonvisual psychological processes. Discussion regarding the effects ofcolor and/or light on nonvisual psychological processes may be found inKnez, Effects of colour of light on nonvisual psychological processes,JOURNAL OF ENVIRONMENTAL PSYCHOLOGY, 21(2):201-08 (2001); M. R BassoJr., Neurobiological relationships between ambient lighting and thestartle response to acoustic stress in humans, INT J NEUROSCI.,110(3-4):147-57 (2001), and Lam et al., The Can-SAD Study: a randomizedcontrolled trial of the effectiveness of light therapy and fluoxetine inpatients with winter seasonal affective disorder, AMERICAN JOURNAL OFPSYCHIATRY, 163(5):805-12 (2006), each incorporated by reference. Insome instances, alterer module 148 may include a computer processor.Further, operation 3806 illustrates altering at least a portion of textof an artificial sensory experience to modify at least one effect of thebioactive agent. For example, as shown in FIG. 32, alterer module 148may alter at least a portion of text of an artificial sensory experienceto modify at least one effect of the bioactive agent. In one instance,alterer module 148 may alter a portion of instructional text in avirtual world including a computer game to alter an effect of abioactive agent including a prescribed herbal memory supplement. Textmodification may improve memory by utilizing techniques such asunderlining, highlighting, boldfacing, and/or mnemonics as discussed inCarney, R. N., & Levin, J. R., Mnemonic instruction with a focus ontransfer, JOURNAL OF EDUCATIONAL PSYCHOLOGY, 92(4):783-90, which isincorporated herein by reference. Another example may includeinstructional text providing contextual or associative information,perhaps individualized, to aid in remembering during the rest of amodule. Another example of text modification and memory may includemodifying the use of interactive components, e.g. via a keyboard and/orspeakers, to use multiple forms of memory input, including visual,auditory, motor, and contextual. For example, this may be used to aidmemory and/or in learning disorders such as dysgraphia, and/or memorydisorders, such as in conjunction with memory-enhancing medications, forexample cholinesterase inhibitors or herbal memory supplements.Additionally, text messages may be added and/or altered based oncognitive therapy but individualized for the person, affliction, and/ormedication (e.g. an antidepressant and instructions to work toward agoal within a game that will aid in refuting automatic negativethoughts). In some instances, alterer module 148 may include a computerprocessor.

FIG. 39 illustrates alternative embodiments of the example operationalflow 3300 of FIG. 33. FIG. 39 illustrates example embodiments where theoperation 3320 may include at least one additional operation. Additionaloperations may include an operation 3902, an operation 3904, anoperation 3906, and/or an operation 3908.

Operation 3902 illustrates altering a sound in an artificial sensoryexperience. For example, as shown in FIG. 32, alterer module 148 mayalter a sound in an artificial sensory experience. In one instance,alterer module 148 may alter a sound in a virtual world including aninstructor's voice tone in an instructional tutorial. This may be doneas a custom-tailored feature. For example, various voice tones may betested with an individual in order to find one that has the mostsignificant benefit for the individual, in conjunction with thebioactive agent. In some instances, alterer module 148 may include acomputer processor. Further, operation 3904 illustrates altering atleast a portion of music in the artificial sensory experience. Forexample, as shown in FIG. 32, alterer module 148 may alter at least aportion of music in the artificial sensory experience. In one instance,alterer module 148 may alter a portion of music including backgroundmusic in an instructional tutorial. Music in the artificial sensoryexperience may include pitch, rhythm, tempo, meter, and articulation,dynamics, lyrics, timbre and texture. In one specific instance, alterermodule 146 may alter a portion of uptempo music to soothing classicalmusic in an artificial sensory experience coupled with administration ofan anxiolytic. Such a music alteration may serve to provide a calmingand/or relaxing environment where the effects of the anxiolytic may befacilitated and/or enhanced. In another instance, a sound pitch may bealtered to affect bone (as in healing fractures and/or promoting bonegrowth) and/or sinuses (including joints). Additionally, alterer module146 may include providing another type of sound, such as a lowfrequency, to aid in healing, e.g. in conjunction with pain medicationand/or an anti-inflammatory medication. In another example, the soundmay originate from a natural source, for instance a purr of a cat,possibly provided at a particular pitch, to aid in relaxation, as inconjunction with a tranquilizer, and/or in healing tissue in conjunctionwith pain medication or anti-inflammatories. Further discussionregarding low frequency therapeutic biomechanical stimulation may befound in von Muggenthaler, E. K., The Felid purr: low frequencytherapeutic biomechanical stimulation, 12th International Conference onLow Frequency Noise and Vibration and its Control, Bristol, UK, Sep.18-20, 2006, Abstract located at Fauna Communications Research Institute<http://animalvoice.com/catpurrP.htm#2pAB7.%20The%20felid%20purr:%20A%20healing%20mechanism?%20Session:%20Tuesday%20Afternoon,%20Dec%2004%20Time:%203:15>, and Simos et al., U.S. patent application Ser. No.11/262,884, each incorporated herein by reference. In some instances,alterer module 148 may include a computer processor.

Further, operation 3906 illustrates altering at least a portion ofambient noise in the artificial sensory experience. For example, asshown in FIG. 32, alterer module 148 may alter at least a portion ofambient noise in the artificial sensory experience. In one instance,alterer module 148 may alter the ambient noise in an artificial sensoryexperience including a level of white noise in the online virtual worldSecond Life. Ambient noise may include white noise, background noise,such as people talking or sounds naturally occurring in nature, and/orroom noise. Changing the level of white noise may enhance the effect ofan attention deficit drug such as Ritatin, or it may enhance thesedative properties of a sleep medication or tranquilizer. Furtherdiscussion of the effects of white noise may be found in Spencer, J. A.et al., White noise and sleep induction, ARCH D IS CHILD 65(1):135-37(1990), which is incorporated by reference. In some instances, alterermodule 148 may include a computer processor. Further, operation 3908illustrates altering at least a portion of voice in the artificialsensory experience. For example, as shown in FIG. 1, alterer module 148may alter at least a portion of voice in the artificial sensoryexperience. In one instance, alterer module 148 may alter a voice rhythmin an online tutorial. Such alteration may enhance the effect of anattention deficit medication, for example by elimination or reduction ofmonotonic qualities in the voice rhythm of the online tutorial, forexample. Some examples of a voice may include a voice recording, anartificially generated voice, and/or a human voice. In some instances,alterer module 148 may include a computer processor.

FIG. 40 illustrates alternative embodiments of the example operationalflow 3300 of FIG. 33. FIG. 40 illustrates example embodiments where theoperation 3320 may include at least one additional operation. Additionaloperations may include an operation 4002, an operation 4004, and/or anoperation 4006.

Operation 4002 illustrates altering an artificial sensory experience toenhance the efficacy of the bioactive agent. For example, as shown inFIG. 32, alterer module 148 may alter an artificial sensory experienceto enhance the efficacy of the bioactive agent. In one instance,modifier module 140 may modify a virtual world by adding uptempo musicto enhance the efficacy of an antidepressant. Further discussion ofmusic effects may be found in Schellenberg, E. G. et al., Exposure tomusic and cognitive performance: tests of children and adults,PSYCHOLOGY OF MUSIC, Vol. 35, No. 1, 5-19 (2007), which is incorporatedherein by reference. In some instances, alterer module 148 may include acomputer processor.

Operation 4004 illustrates altering an artificial sensory experience toreduce a side effect of the bioactive agent. For example, as shown inFIG. 32, alterer module 148 may alter an artificial sensory experienceto reduce a side effect of the bioactive agent. In one instance,modifier module 140 may modify a virtual world by adding music and/orsounds occurring in nature for reducing a side effect including aheadache due to an administration of penicillin. Further discussion ofmusic effects upon a side effect may be found in Siedliecki, S. L. andGood, M., Effect of music on power, pain, depression and disability,JOURNAL OF ADVANCED NURSING 54(5):553-62 (2006), and Naturaldistractions reduce pain—study finds that sights and sounds of natureaid in pain reduction—Brief Article, MEN'S FITNESS. October 2001, eachincorporated by reference. In some instances, alterer module 148 mayinclude a computer processor.

Operation 4006 illustrates adding at least one of visual or audiocontent to the artificial sensory experience. For example, as shown inFIG. 32, adder module 154 may add at least one of visual or audiocontent to the artificial sensory experience. In one instance, addermodule 154 may add audio content including calming music to anartificial sensory experience including a virtual world for treating aphobia of heights. The adding function may include increasing, creating,and/or combining content. Some examples of visual content may includevisual objects, light amount and/or intensity, and/or color schemes.Examples of audio content may include music, voices, artificial sounds,and/or white noise. In some instances, adder module 154 may include acomputer processor.

FIG. 41 illustrates alternative embodiments of the example operationalflow 3300 of FIG. 33. FIG. 41 illustrates example embodiments where theoperation 3320 may include at least one additional operation. Additionaloperations may include an operation 4102, an operation 4104, anoperation 4106, and/or an operation 4108.

Operation 4102 illustrates deleting at least one of visual or audiocontent of the artificial sensory experience. For example, as shown inFIG. 32, deleter module 156 may delete at least one of visual or audiocontent of the artificial sensory experience. In one instance, deletermodule 156 may delete visual content including a bright lightingenvironment in a virtual world for enhancing the effect of a medicationfor migraine headache. Deleting may include reducing and/or eliminatingvisual and/or audio content. In some instances, deleter module 156 mayinclude a computer processor.

Operation 4104 illustrates adding content to the artificial sensoryexperience and deleting different content of the artificial sensoryexperience. For example, as shown in FIG. 32, adder module 154 may addcontent to the artificial sensory experience and deleter module 156 maydelete different content of the artificial sensory experience. In oneinstance, adder module 154 may add classical background music to avirtual world and deleter module 156 may delete ambient street noise,for example, using sound detection and/or noise-cancellation technology,to enhance the effect of a sedative or other similar bioactive agent. Insome instances, adder module 154 and/or deleter module 156 may include acomputer processor.

Operation 4106 illustrates altering a sensate experience to modify theat least one effect of the bioactive agent. For example, as shown inFIG. 32, alterer module 148 may alter a sensate experience to modify theat least one effect of the bioactive agent. In one instance, modifiermodule 140 may modify a sensate experience including adding an aroma toenhance the effect of an anxiolytic drug or other similar bioactiveagent. A sensate experience may include a thing perceived by the senses,such as an aroma, a sound, a feel, a taste, and/or a sight. In someinstances, alterer module 148 may include a computer processor.

Further, operation 4108 illustrates altering at least one of anolfactory stimulus, a haptic stimulus, a visual stimulus, an auditorystimulus, or a taste stimulus to modify the at least one effect of thebioactive agent. For example, as shown in FIG. 32, alterer module 148may alter at least one of an olfactory stimulus, a haptic stimulus, avisual stimulus, an auditory stimulus, or a taste stimulus to modify theat least one effect of the bioactive agent. In one instance, alterermodule 148 may alter an olfactory stimulus by adding a floral aromaand/or gentle vibration to enhance a relaxing effect of a sedative orother similar bioactive agent, such as an antianxiety medication.Further discussion of an olfactory stimulus may be found in Shaw, D. etal., Anxiolytic effects of lavender oil inhalation on open-fieldbehaviour in rats, PHYTOMEDICINE, 14(9):613-20 (2007), incorporated byreference. In some instances, alterer module 148 may include a computerprocessor.

FIG. 42 illustrates alternative embodiments of the example operationalflow 3300 of FIG. 33. FIG. 42 illustrates example embodiments where theoperation 3320 may include at least one additional operation. Additionaloperations may include an operation 4202, an operation 4204, and/or anoperation 4206.

Operation 4202 illustrates altering an artificial sensory experienceimplemented on a mobile device. For example, as shown in FIG. 32,alterer module 148 may alter an artificial sensory experienceimplemented on a mobile device. In one instance, modifier module 140 maymodify a virtual world implemented in a web browser on a laptop computerhaving wireless capability and a battery by changing a background colortheme to a brighter color theme in the virtual world. An artificialsensory experience alteration, such as the color change in the aboveexample, may enhance the effect of a bioactive agent. For example,creating a more pleasant environment in the artificial sensoryexperience by altering the color theme in the above example may enhancethe anti-depressant drug effect while an anti-depressant isbioavailable. Some examples of a mobile device may include a laptop ornotebook computer, a personal digital assistant (PDA), an ipod, asmartphone, an Enterprise digital assistant (EDA), and/or a pager. Inanother example, modifier module 140 may modify a city image byproviding a soothing image having fewer people in the same part of thecity and combining the modified image with an anti-anxiety medicine foralleviating a phobia, such as agoraphobia. In another example, modifiermodule 140 may provide a stepwise procedure, with a gradually lessspecific procedure and/or less steps, for a compulsive patient to followto achieve a goal for a particular outing while taking a selectiveserotonin reuptake inhibitor (SSRI). In some instances, alterer module148 may include a computer processor.

Operation 4204 illustrates detecting at least one of a pain medication,an antianxiety medication, an anti-addiction medication, an anti-obesitymedication, or a mood-altering medication prescribed for the individualand altering an artificial sensory experience to modify at least oneeffect of the bioactive agent. For example, as shown in FIG. 32,detector module 140 may detect at least one of a pain medication, anantianxiety medication, an anti-addiction medication, an anti-obesitymedication, or a mood-altering medication prescribed for the individualand altering an artificial sensory experience to modify at least oneeffect of the bioactive agent. In one instance, detector module 140 maydetect an identification of a pain medication. A pain medication, or ananalgesic, may include a drug and/or other medication suitable forrelieving pain. Additionally, an analgesic may be effective forrelieving different degrees of pain. Some examples of an analgesic mayinclude narcotics such as morphine or oxycodone, non-narcotics, an NSAIDsuch as aspirin or naproxen or ibuprofen, and/or acetaminophen. Anantianxiety drug may include a drug for suppressing anxiety and relaxingthe muscles. An antianxiety drug may include a sedative, a tranquilizer,an anxiolytic, such as a benzodiazepine, alprazolam and/or diazepam, anantidepressant, a short-acting barbiturate, and/or an herbal treatment,such as chamomile, kava extract, Kratom, and/or valerian. Ananti-addiction medication may include a substance used to replaceanother addictive substance, treat withdrawal, and/or decrease and/oreliminate craving. One example of an anti-addiction medication mayinclude ibogaine. An anti-obesity medication may include apharmacological treatment intended to reduce or control weight. Someexamples of an anti-obesity medication may include orlistat,sibutramine, and/or pyruvate. A mood-altering medication may include apsychiatric medication used to treat mood disorders characterized byintense and sustained mood shifts. Some examples of a mood stabilizermay include lithium carbonate and/or lamotrigine. Additionally,modifying an artificial sensory experience may include a modificationfor enhancing positive aspects of behavior, such as improvinginformation retention, reaction time, hearing acuity, attention span,and/or mental stamina. In some instances, detector module 140 mayinclude a computer processor.

Operation 4206 illustrates detecting an anti-depressant medication inthe individual and adding at least one cheerful attribute to a virtualworld experience to increase an anti-depressive effect of theanti-depressant medication. For example, as shown in FIG. 32, detectormodule 140 may detect an anti-depressant medication in the individualand adding at least one cheerful attribute to a virtual world experienceto increase an anti-depressive effect of the anti-depressant medication.For example, upon receipt of an indication that an individual is takingprozac, system 3300 and/or adder module 154 may place a filter over thegraphics of the individual's facebook webpage that presents a brightcolor scheme that can enhance the anti-depressant effect of the prozac.In some instances, detector module 140 and/or adder module 154 mayinclude a computer processor.

FIG. 43 illustrates a partial view of an example computer programproduct 4300 that includes a computer program 4304 for executing acomputer process on a computing device. An embodiment of the examplecomputer program product 4300 is provided using a signal-bearing medium4302, and may include one or more instructions for detecting at leastone indication of bioactive agent use by an individual and one or moreinstructions for altering an artificial sensory experience to modify atleast one effect of the bioactive agent. The one or more instructionsmay be, for example, computer executable and/or logic-implementedinstructions. In one implementation, the signal-bearing medium 4302 mayinclude a computer-readable medium 4306. In one implementation, thesignal bearing medium 4302 may include a recordable medium 4308. In oneimplementation, the signal bearing medium 4302 may include acommunications medium 4310.

FIG. 44 illustrates an example system 4400 in which embodiments may beimplemented. The system 4400 includes a computing system environment.The system 4400 also illustrates the user 118 using a device 4404, whichis optionally shown as being in communication with a computing device4402 by way of an optional coupling 4406. The optional coupling 4406 mayrepresent a local, wide-area, or peer-to-peer network, or may representa bus that is internal to a computing device (e.g., in exampleembodiments in which the computing device 4402 is contained in whole orin part within the device 4404). A storage medium 4408 may be anycomputer storage media.

The computing device 4402 includes computer-executable instructions 4410that when executed on the computing device 4402 cause the computingdevice 4402 to detect at least one indication of bioactive agent use byan individual and alter an artificial sensory experience to modify atleast one effect of the bioactive agent. As referenced above and asshown in FIG. 43, in some examples, the computing device 4402 mayoptionally be contained in whole or in part within the device 4404.

In FIG. 44, then, the system 4400 includes at least one computing device(e.g., 4402 and/or 4404). The computer-executable instructions 4410 maybe executed on one or more of the at least one computing device. Forexample, the computing device 4402 may implement the computer-executableinstructions 4410 and output a result to (and/or receive data from) thecomputing device 4404. Since the computing device 4402 may be wholly orpartially contained within the computing device 4404, the device 4404also may be said to execute some or all of the computer-executableinstructions 4410, in order to be caused to perform or implement, forexample, various ones of the techniques described herein, or othertechniques.

The device 4404 may include, for example, a portable computing device,workstation, or desktop computing device. In another example embodiment,the computing device 4402 is operable to communicate with the device4404 associated with the user 118 to detect at least one indication ofbioactive agent use by an individual and alter an artificial sensoryexperience to modify at least one effect of the bioactive agent.

Although a user 118 is shown/described herein as a single illustratedfigure, those skilled in the art will appreciate that a user 118 may berepresentative of a human user, a robotic user (e.g., computationalentity), and/or substantially any combination thereof (e.g., a user maybe assisted by one or more robotic agents). In addition, a user 118, asset forth herein, although shown as a single entity may in fact becomposed of two or more entities. Those skilled in the art willappreciate that, in general, the same may be said of “sender” and/orother entity-oriented terms as such terms are used herein.

Following are a series of flowcharts depicting implementations. For easeof understanding, the flowcharts are organized such that the initialflowcharts present implementations via an example implementation andthereafter the following flowcharts present alternate implementationsand/or expansions of the initial flowchart(s) as either sub-componentoperations or additional component operations building on one or moreearlier-presented flowcharts. Those having skill in the art willappreciate that the style of presentation utilized herein (e.g.,beginning with a presentation of a flowchart(s) presenting an exampleimplementation and thereafter providing additions to and/or furtherdetails in subsequent flowcharts) generally allows for a rapid and easyunderstanding of the various process implementations. In addition, thoseskilled in the art will further appreciate that the style ofpresentation used herein also lends itself well to modular and/orobject-oriented program design paradigms.

Those skilled in the art will appreciate that the foregoing specificexemplary processes and/or devices and/or technologies arerepresentative of more general processes and/or devices and/ortechnologies taught elsewhere herein, such as in the claims filedherewith and/or elsewhere in the present application.

Those having skill in the art will recognize that the state of the arthas progressed to the point where there is little distinction leftbetween hardware, software, and/or firmware implementations of aspectsof systems; the use of hardware, software, and/or firmware is generally(but not always, in that in certain contexts the choice between hardwareand software can become significant) a design choice representing costvs. efficiency tradeoffs. Those having skill in the art will appreciatethat there are various vehicles by which processes and/or systems and/orother technologies described herein can be effected (e.g., hardware,software, and/or firmware), and that the preferred vehicle will varywith the context in which the processes and/or systems and/or othertechnologies are deployed. For example, if an implementer determinesthat speed and accuracy are paramount, the implementer may opt for amainly hardware and/or firmware vehicle; alternatively, if flexibilityis paramount, the implementer may opt for a mainly softwareimplementation; or, yet again alternatively, the implementer may opt forsome combination of hardware, software, and/or firmware. Hence, thereare several possible vehicles by which the processes and/or devicesand/or other technologies described herein may be effected, none ofwhich is inherently superior to the other in that any vehicle to beutilized is a choice dependent upon the context in which the vehiclewill be deployed and the specific concerns (e.g., speed, flexibility, orpredictability) of the implementer, any of which may vary. Those skilledin the art will recognize that optical aspects of implementations willtypically employ optically-oriented hardware, software, and/or firmware.

In some implementations described herein, logic and similarimplementations may include software or other control structuressuitable to operation. Electronic circuitry, for example, may manifestone or more paths of electrical current constructed and arranged toimplement various logic functions as described herein. In someimplementations, one or more media are configured to bear adevice-detectable implementation if such media hold or transmit aspecial-purpose device instruction set operable to perform as describedherein. In some variants, for example, this may manifest as an update orother modification of existing software or firmware, or of gate arraysor other programmable hardware, such as by performing a reception of ora transmission of one or more instructions in relation to one or moreoperations described herein. Alternatively or additionally, in somevariants, an implementation may include special-purpose hardware,software, firmware components, and/or general-purpose componentsexecuting or otherwise invoking special-purpose components.Specifications or other implementations may be transmitted by one ormore instances of tangible transmission media as described herein,optionally by packet transmission or otherwise by passing throughdistributed media at various times.

Alternatively or additionally, implementations may include executing aspecial-purpose instruction sequence or otherwise invoking circuitry forenabling, triggering, coordinating, requesting, or otherwise causing oneor more occurrences of any functional operations described above. Insome variants, operational or other logical descriptions herein may beexpressed directly as source code and compiled or otherwise invoked asan executable instruction sequence. In some contexts, for example, C++or other code sequences can be compiled directly or otherwiseimplemented in high-level descriptor languages (e.g., alogic-synthesizable language, a hardware description language, ahardware design simulation, and/or other such similar mode(s) ofexpression). Alternatively or additionally, some or all of the logicalexpression may be manifested as a Verilog-type hardware description orother circuitry model before physical implementation in hardware,especially for basic operations or timing-critical applications. Thoseskilled in the art will recognize how to obtain, configure, and optimizesuitable transmission or computational elements, material supplies,actuators, or other common structures in light of these teachings.

The foregoing detailed description has set forth various embodiments ofthe devices and/or processes via the use of block diagrams, flowcharts,and/or examples. Insofar as such block diagrams, flowcharts, and/orexamples contain one or more functions and/or operations, it will beunderstood by those within the art that each function and/or operationwithin such block diagrams, flowcharts, or examples can be implemented,individually and/or collectively, by a wide range of hardware, software,firmware, or virtually any combination thereof. In one embodiment,several portions of the subject matter described herein may beimplemented via Application Specific Integrated Circuits (ASICs), FieldProgrammable Gate Arrays (FPGAs), digital signal processors (DSPs), orother integrated formats. However, those skilled in the art willrecognize that some aspects of the embodiments disclosed herein, inwhole or in part, can be equivalently implemented in integratedcircuits, as one or more computer programs running on one or morecomputers (e.g., as one or more programs running on one or more computersystems), as one or more programs running on one or more processors(e.g., as one or more programs running on one or more microprocessors),as firmware, or as virtually any combination thereof, and that designingthe circuitry and/or writing the code for the software and or firmwarewould be well within the skill of one of skill in the art in light ofthis disclosure. In addition, those skilled in the art will appreciatethat the mechanisms of the subject matter described herein are capableof being distributed as a program product in a variety of forms, andthat an illustrative embodiment of the subject matter described hereinapplies regardless of the particular type of signal bearing medium usedto actually carry out the distribution. Examples of a signal bearingmedium include, but are not limited to, the following: a recordable typemedium such as a floppy disk, a hard disk drive, a Compact Disc (CD), aDigital Video Disk (DVD), a digital tape, a computer memory, etc.; and atransmission type medium such as a digital and/or an analogcommunication medium (e.g., a fiber optic cable, a waveguide, a wiredcommunications link, a wireless communication link (e.g., transmitter,receiver, transmission logic, reception logic, etc.), etc.).

In a general sense, those skilled in the art will recognize that thevarious embodiments described herein can be implemented, individuallyand/or collectively, by various types of electromechanical systemshaving a wide range of electrical components such as hardware, software,firmware, and/or virtually any combination thereof; and a wide range ofcomponents that may impart mechanical force or motion such as rigidbodies, spring or torsional bodies, hydraulics, electro-magneticallyactuated devices, and/or virtually any combination thereof.Consequently, as used herein “electro-mechanical system” includes, butis not limited to, electrical circuitry operably coupled with atransducer (e.g., an actuator, a motor, a piezoelectric crystal, a MicroElectro Mechanical System (MEMS), etc.), electrical circuitry having atleast one discrete electrical circuit, electrical circuitry having atleast one integrated circuit, electrical circuitry having at least oneapplication specific integrated circuit, electrical circuitry forming ageneral purpose computing device configured by a computer program (e.g.,a general purpose computer configured by a computer program which atleast partially carries out processes and/or devices described herein,or a microprocessor configured by a computer program which at leastpartially carries out processes and/or devices described herein),electrical circuitry forming a memory device (e.g., forms of memory(e.g., random access, flash, read only, etc.)), electrical circuitryforming a communications device (e.g., a modem, communications switch,optical-electrical equipment, etc.), and/or any non-electrical analogthereto, such as optical or other analogs. Those skilled in the art willalso appreciate that examples of electro-mechanical systems include butare not limited to a variety of consumer electronics systems, medicaldevices, as well as other systems such as motorized transport systems,factory automation systems, security systems, and/orcommunication/computing systems. Those skilled in the art will recognizethat electro-mechanical as used herein is not necessarily limited to asystem that has both electrical and mechanical actuation except ascontext may dictate otherwise.

In a general sense, those skilled in the art will recognize that thevarious aspects described herein which can be implemented, individuallyand/or collectively, by a wide range of hardware, software, firmware,and/or any combination thereof can be viewed as being composed ofvarious types of “electrical circuitry.” Consequently, as used herein“electrical circuitry” includes, but is not limited to, electricalcircuitry having at least one discrete electrical circuit, electricalcircuitry having at least one integrated circuit, electrical circuitryhaving at least one application specific integrated circuit, electricalcircuitry forming a general purpose computing device configured by acomputer program (e.g., a general purpose computer configured by acomputer program which at least partially carries out processes and/ordevices described herein, or a microprocessor configured by a computerprogram which at least partially carries out processes and/or devicesdescribed herein), electrical circuitry forming a memory device (e.g.,forms of memory (e.g., random access, flash, read only, etc.)), and/orelectrical circuitry forming a communications device (e.g., a modem,communications switch, optical-electrical equipment, etc.). Those havingskill in the art wilt recognize that the subject matter described hereinmay be implemented in an analog or digital fashion or some combinationthereof.

Those skilled in the art will recognize that at least a portion of thedevices and/or processes described herein can be integrated into a dataprocessing system. Those having skill in the art will recognize that adata processing system generally includes one or more of a system unithousing, a video display device, memory such as volatile or non-volatilememory, processors such as microprocessors or digital signal processors,computational entities such as operating systems, drivers, graphicaluser interfaces, and applications programs, one or more interactiondevices (e.g., a touch pad, a touch screen, an antenna, etc.), and/orcontrol systems including feedback loops and control motors (e.g.,feedback for sensing position and/or velocity; control motors for movingand/or adjusting components and/or quantities). A data processing systemmay be implemented utilizing suitable commercially available components,such as those typically found in data computing/communication and/ornetwork computing/communication systems.

Those skilled in the art will recognize that it is common within the artto implement devices and/or processes and/or systems, and thereafter useengineering and/or other practices to integrate such implemented devicesand/or processes and/or systems into more comprehensive devices and/orprocesses and/or systems. That is, at least a portion of the devicesand/or processes and/or systems described herein can be integrated intoother devices and/or processes and/or systems via a reasonable amount ofexperimentation. Those having skill in the art will recognize thatexamples of such other devices and/or processes and/or systems mightinclude—as appropriate to context and application—all or part of devicesand/or processes and/or systems of (a) an air conveyance (e.g., anairplane, rocket, helicopter, etc.), (b) a ground conveyance (e.g., acar, truck, locomotive, tank, armored personnel carrier, etc.), (c) abuilding (e.g., a home, warehouse, office, etc.), (d) an appliance(e.g., a refrigerator, a washing machine, a dryer, etc.), (e) acommunications system (e.g., a networked system, a telephone system, aVoice over IP system, etc.), (f) a business entity (e.g., an InternetService Provider (ISP) entity such as Comcast Cable, Qwest, SouthwesternBell, etc.), or (g) a wired/wireless services entity (e.g., Sprint,Cingular, Nextel, etc.), etc.

In certain cases, use of a system or method may occur in a territoryeven if components are located outside the territory. For example, in adistributed computing context, use of a distributed computing system mayoccur in a territory even though parts of the system may be locatedoutside of the territory (e.g., relay, server, processor, signal-bearingmedium, transmitting computer, receiving computer, etc. located outsidethe territory).

A sale of a system or method may likewise occur in a territory even ifcomponents of the system or method are located and/or used outside theterritory.

Further, implementation of at least part of a system for performing amethod in one territory does not preclude use of the system in anotherterritory.

All of the above U.S. patents, U.S. patent application publications,U.S. patent applications, foreign patents, foreign patent applicationsand non-patent publications referred to in this specification and/orlisted in any Application Data Sheet, are incorporated herein byreference, to the extent not inconsistent herewith.

One skilled in the art will recognize that the herein describedcomponents (e.g., operations), devices, objects, and the discussionaccompanying them are used as examples for the sake of conceptualclarity and that various configuration modifications are contemplated.Consequently, as used herein, the specific exemplars set forth and theaccompanying discussion are intended to be representative of their moregeneral classes. In general, use of any specific exemplar is intended tobe representative of its class, and the non-inclusion of specificcomponents (e.g., operations), devices, and objects should not be takenlimiting.

Although user 118 is shown/described herein as a single illustratedfigure, those skilled in the art will appreciate that user 118 may berepresentative of a human user, a robotic user (e.g., computationalentity), and/or substantially any combination thereof (e.g., a user maybe assisted by one or more robotic agents) unless context dictatesotherwise. Those skilled in the art will appreciate that, in general,the same may be said of “sender” and/or other entity-oriented terms assuch terms are used herein unless context dictates otherwise.

With respect to the use of substantially any plural and/or singularterms herein, those having skill in the art can translate from theplural to the singular and/or from the singular to the plural as isappropriate to the context and/or application. The varioussingular/plural permutations are not expressly set forth herein for sakeof clarity.

The herein described subject matter sometimes illustrates differentcomponents contained within, or connected with, different othercomponents. It is to be understood that such depicted architectures aremerely exemplary, and that in fact many other architectures may beimplemented which achieve the same functionality. In a conceptual sense,any arrangement of components to achieve the same functionality iseffectively “associated” such that the desired functionality isachieved. Hence, any two components herein combined to achieve aparticular functionality can be seen as “associated with” each othersuch that the desired functionality is achieved, irrespective ofarchitectures or intermedial components. Likewise, any two components soassociated can also be viewed as being “operably connected”, or“operably coupled,” to each other to achieve the desired functionality,and any two components capable of being so associated can also be viewedas being “operably couplable,” to each other to achieve the desiredfunctionality. Specific examples of operably couplable include but arenot limited to physically mateable and/or physically interactingcomponents, and/or wirelessly interactable, and/or wirelesslyinteracting components, and/or logically interacting, and/or logicallyinteractable components.

In some instances, one or more components may be referred to herein as“configured to,” “configurable to,” “operable/operative to,”“adapted/adaptable,” “able to,” “conformable/conformed to,” etc. Thoseskilled in the art will recognize that “configured to” can generallyencompass active-state components and/or inactive-state componentsand/or standby-state components, unless context requires otherwise.

While particular aspects of the present subject matter described hereinhave been shown and described, it will be apparent to those skilled inthe art that, based upon the teachings herein, changes and modificationsmay be made without departing from the subject matter described hereinand its broader aspects and, therefore, the appended claims are toencompass within their scope all such changes and modifications as arewithin the true spirit and scope of the subject matter described herein.It will be understood by those within the art that, in general, termsused herein, and especially in the appended claims (e.g., bodies of theappended claims) are generally intended as “open” terms (e.g., the term“including” should be interpreted as “including but not limited to,” theterm “having” should be interpreted as “having at least,” the term“includes” should be interpreted as “includes but is not limited to,”etc.). It will be further understood by those within the art that if aspecific number of an introduced claim recitation is intended, such anintent will be explicitly recited in the claim, and in the absence ofsuch recitation no such intent is present. For example, as an aid tounderstanding, the following appended claims may contain usage of theintroductory phrases “at least one” and “one or more” to introduce claimrecitations. However, the use of such phrases should not be construed toimply that the introduction of a claim recitation by the indefinitearticles “a” or “an” limits any particular claim containing suchintroduced claim recitation to claims containing only one suchrecitation, even when the same claim includes the introductory phrases“one or more” or “at least one” and indefinite articles such as “a” or“an” (e.g., “a” and/or “an” should typically be interpreted to mean “atleast one” or “one or more”); the same holds true for the use ofdefinite articles used to introduce claim recitations. In addition, evenif a specific number of an introduced claim recitation is explicitlyrecited, those skilled in the art will recognize that such recitationshould typically be interpreted to mean at least the recited number(e.g., the bare recitation of “two recitations,” without othermodifiers, typically means at least two recitations, or two or morerecitations). Furthermore, in those instances where a conventionanalogous to “at least one of A, B, and C, etc.” is used, in generalsuch a construction is intended in the sense one having skill in the artwould understand the convention (e.g., “a system having at least one ofA, B, and C” would include but not be limited to systems that have Aalone, B alone, C alone, A and B together, A and C together, B and Ctogether, and/or A, B, and C together, etc.). In those instances where aconvention analogous to “at least one of A, B, or C, etc.” is used, ingeneral such a construction is intended in the sense one having skill inthe art would understand the convention (e.g., “a system having at leastone of A, B, or C” would include but not be limited to systems that haveA alone, B alone, C alone, A and B together, A and C together, B and Ctogether, and/or A, B, and C together, etc.). It will be furtherunderstood by those within the art that typically a disjunctive wordand/or phrase presenting two or more alternative terms, whether in thedescription, claims, or drawings, should be understood to contemplatethe possibilities of including one of the terms, either of the terms, orboth terms unless context dictates otherwise. For example, the phrase “Aor B” will be typically understood to include the possibilities of “A”or “B” or “A and B.”

With respect to the appended claims, those skilled in the art willappreciate that recited operations therein may generally be performed inany order. Also, although various operational flows are presented in asequence(s), it should be understood that the various operations may beperformed in other orders than those which are illustrated, or may beperformed concurrently. Examples of such alternate orderings may includeoverlapping, interleaved, interrupted, reordered, incremental,preparatory, supplemental, simultaneous, reverse, or other variantorderings, unless context dictates otherwise. Furthermore, terms like“responsive to,” “related to,” or other past-tense adjectives aregenerally not intended to exclude such variants, unless context dictatesotherwise.

While various aspects and embodiments have been disclosed herein, otheraspects and embodiments will be apparent to those skilled in the art.The various aspects and embodiments disclosed herein are for purposes ofillustration and are not intended to be limiting, with the true scopeand spirit being indicated by the following claims.

1. A computer-implemented method comprising: detecting at least oneindication of bioactive agent use by an individual; and altering anartificial sensory experience to modify at least one effect of thebioactive agent.
 2. A system comprising: means for detecting at leastone indication of bioactive agent use by an individual; and means foraltering an artificial sensory experience to modify at least one effectof the bioactive agent.
 3. The system of claim 2 wherein the means fordetecting at least one indication of bioactive agent use by anindividual comprises: means for analyzing at least one of sweat, blood,breath, heart rate, brain activity, respiration, or voice quality todetect the at least one indication of bioactive agent use by theindividual.
 4. The system of claim 3 wherein the means for analyzing atleast one of sweat, blood, breath, heart rate, brain activity,respiration, or voice quality to detect the at least one indication ofbioactive agent use by the individual comprises: means for analyzingbrain activity using at least one of near infra-red imaging, EEG,magnetoencephalography, functional magnetic resonance imaging, orcomputer-aided tomography.
 5. The system of claim 3 wherein the meansfor analyzing at least one of sweat, blood, breath, heart rate, brainactivity, respiration, or voice quality to detect the at least oneindication of bioactive agent use by the individual comprises: means fordetecting at least one of an anti-depressant, an anxiolytic medication,a pain medication, a behavior modifying medication, a weight modifyingdrug, a neurodegenerative disorder medication, or a vascular diseasemedication as the at least one medication.
 6. The system of claim 2wherein the means for detecting at least one indication of bioactiveagent use by an individual comprises: means for detecting aconcentration of the bioactive agent in the individual.
 7. The system ofclaim 2 wherein the means for detecting at least one indication ofbioactive agent use by an individual comprises: means for comparing ameasured value of the bioactive agent in the individual to a storedbaseline value of the bioactive agent for the individual to identify adifferential indicative of bioactive agent use.
 8. The system of claim 2wherein the means for detecting at least one indication of bioactiveagent use by an individual comprises: means for detecting substance useby the individual.
 9. The system of claim 8 wherein the means fordetecting substance use by the individual comprises: means for detectingat least one of alcohol use, psychoactive drug use, tranquilizer use,methamphetamine use, or narcotic use.
 10. The system of claim 2 whereinthe means for detecting at least one indication of bioactive agent useby an individual comprises: means for detecting a nutraceutical used bythe individual.
 11. The system of claim 10 wherein the means fordetecting a nutraceutical used by the individual comprises: means fordetecting at least one of a memory supplement, an anti-oxidant, a cancerpreventative, or a mood-changing agent.
 12. The system of claim 2wherein the means for detecting at least one indication of bioactiveagent use by an individual comprises: means for detecting at least oneindication of bioactive agent use by at least one of a computer gameparticipant, a social networking website participant, a virtual worldparticipant, an online student, an online medical information user, oran on-line shopper.
 13. The system of claim 2 wherein the means foraltering an artificial sensory experience to modify at least one effectof the bioactive agent comprises: means for altering access to at leasta portion of the artificial sensory experience to modify at least oneeffect of the bioactive agent.
 14. The system of claim 13 wherein themeans for altering access to at least a portion of the artificialsensory experience to modify at least one effect of the bioactive agentcomprises: means for restricting access to at least a portion of theartificial sensory experience.
 15. The system of claim 13 wherein themeans for altering access to at least a portion of the artificialsensory experience to modify at least one effect of the bioactive agentcomprises: means for granting access to at least a portion of theartificial sensory experience.
 16. The system of claim 2 wherein themeans for altering an artificial sensory experience to modify at leastone effect of the bioactive agent comprises: means for altering a visualobject in an artificial sensory experience to modify at least one effectof the bioactive agent.
 17. The system of claim 16 wherein the means foraltering a visual object in an artificial sensory experience to modifyat least one effect of the bioactive agent comprises: means for alteringa color scheme of an artificial sensory experience to modify at leastone effect of the bioactive agent.
 18. The system of claim 16 whereinthe means for altering a visual object in an artificial sensoryexperience to modify at least one effect of the bioactive agentcomprises: means for altering at least a portion of text of anartificial sensory experience to modify at least one effect of thebioactive agent.
 19. The system of claim 2 wherein the means foraltering an artificial sensory experience to modify at least one effectof the bioactive agent comprises: means for altering a sound in anartificial sensory experience.
 20. The system of claim 19 wherein themeans for altering a sound in an artificial sensory experiencecomprises: means for altering at least a portion of music in theartificial sensory experience.
 21. The system of claim 19 wherein themeans for altering a sound in an artificial sensory experiencecomprises: means for altering at least a portion of ambient noise in theartificial sensory experience.
 22. The system of claim 19 wherein themeans for altering a sound in an artificial sensory experiencecomprises: means for altering at least a portion of voice in theartificial sensory experience.
 23. The system of claim 2 wherein themeans for altering an artificial sensory experience to modify at leastone effect of the bioactive agent comprises: means for altering anartificial sensory experience to enhance the efficacy of the bioactiveagent.
 24. The system of claim 2 wherein the means for altering anartificial sensory experience to modify at least one effect of thebioactive agent comprises: means for altering an artificial sensoryexperience to reduce a side effect of the bioactive agent.
 25. Thesystem of claim 2 wherein the means for altering an artificial sensoryexperience to modify at least one effect of the bioactive agentcomprises: means for adding at least one of visual or audio content tothe artificial sensory experience.
 26. The system of claim 2 wherein themeans for altering an artificial sensory experience to modify at leastone effect of the bioactive agent comprises: means for deleting at leastone of visual or audio content of the artificial sensory experience. 27.The system of claim 2 wherein the means for altering an artificialsensory experience to modify at least one effect of the bioactive agentcomprises: means for adding content to the artificial sensory experienceand deleting different content of the artificial sensory experience. 28.The system of claim 2 wherein the means for altering an artificialsensory experience to modify at least one effect of the bioactive agentcomprises: means for altering a sensate experience to modify the atleast one effect of the bioactive agent.
 29. The system of claim 28wherein the means for altering a sensate experience to modify the atleast one effect of the bioactive agent comprises: means for altering atleast one of an olfactory stimulus, a haptic stimulus, a visualstimulus, an auditory stimulus, or a taste stimulus to modify the atleast one effect of the bioactive agent.
 30. The system of claim 2wherein the means for altering an artificial sensory experience tomodify at least one effect of the bioactive agent comprises: means foraltering an artificial sensory experience implemented on a mobiledevice.
 31. The computer-implemented method of claim 2 wherein the meansfor detecting at least one indication of bioactive agent use by anindividual and the means for altering an artificial sensory experienceto modify at least one effect of the bioactive agent comprise: means fordetecting at least one of a pain medication, an antianxiety medication,an anti-addiction medication, an anti-obesity medication, or amood-altering medication prescribed for the individual and altering anartificial sensory experience to modify at least one effect of thebioactive agent.
 32. The system of claim 2 wherein the means fordetecting at least one indication of bioactive agent use by anindividual and the means for altering an artificial sensory experienceto modify at least one effect of the bioactive agent comprise: means fordetecting an anti-depressant medication in the individual and adding atleast one cheerful attribute to a virtual world experience to increasean anti-depressive effect of the anti-depressant medication.
 33. Asystem comprising: circuitry for detecting at least one indication ofbioactive agent use by an individual; and circuitry for altering anartificial sensory experience to modify at least one effect of thebioactive agent.
 34. A computer program product comprising: asignal-bearing medium bearing one or more instructions for detecting atleast one indication of bioactive agent use by an individual; and one ormore instructions for altering an artificial sensory experience tomodify at least one effect of the bioactive agent.
 35. The computerprogram product of claim 34, wherein the signal-bearing medium includesa computer-readable medium.
 36. The computer program product of claim34, wherein the signal-bearing medium includes a recordable medium. 37.The computer program product of claim 34, wherein the signal-bearingmedium includes a communications medium.
 38. A system comprising: acomputing device; and instructions that when executed on the computingdevice cause the computing device to detect at least one indication ofbioactive agent use by an individual; and alter an artificial sensoryexperience to modify at least one effect of the bioactive agent.
 39. Thesystem of claim 38 wherein the computing device comprises: one or moreof a personal digital assistant (PDA), a personal entertainment device,a mobile phone, a laptop computer, a tablet personal computer, anetworked computer, a computing system comprised of a cluster ofprocessors, a computing system comprised of a cluster of servers, aworkstation computer, and/or a desktop computer.
 40. The system of claim38, wherein the computing device is operable to accept the at least oneattribute of the at least one individual and present the indication ofthe at least one prescription medication and the at least one artificialsensory experience from at least one memory.